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1. INTRODUCTION 
 
“Retroviruses are unique among infectious agents, both in the way they interact with the host 
cells and organism and in the consequence of this interaction - not only to the life of the 
infected host but also in some cases to the host’s descendants. No other infectious agent of 
higher eukaryotes regularly integrates its genetic information into the host genome; no other 
regularly acquires host genes into its genome, no other can infect the germ line of its host; no 
other has played such an important part in so many aspects of modern biology.” (Coffin, 
1997) 
 
1.1 History of retroviral research (Cann, 2001; Coffin, 1997) 
 
• 1908: Vilhelm Ellerman and Oluf Bang, were studying leukemia in chickens and 
succeeded in transferring the disease from one to another by cell-free tissue filtrates.  
• 1911: Peyton Rous reported cell free transmission of sarcoma in chicken and isolated 
the infectious agent Rous sarcoma Virus (RSV).  
• 1951: Gross observed vertical (germ line) transmission of cancers 
• 1957: The Friend murine leukemia virus discovered by Charlotte Friend provided an 
animal model system for the study of erythropoiesis and the multistep nature of 
cancer. 
• 1960's: Howard Temin knew that retrovirus genomes were composed of RNA and 
observed that replication was inhibited by actinomycin D (that inhibits DNA 
synthesis), this drug doesn’t inhibit the replication of other RNA viruses. Temin and 
Baltimore simultaneously demonstrated that retrovirus particles contain an RNA-
dependent DNA polymerase-reverse transcriptase (Nobel prize awarded to Baltimore 
and Temin, 1975).  
• 1969: Huebner and Todaro proposed the viral oncogene hypothesis - the transmission 
of viral and oncogenic information as genetic elements. This explained the vertical 
(germ line) transmission of 'cancers', first observed by Gross, 1951.  
• 1981: Gallo and co-workers discovered Human T-cell leukaemia virus, which was the 
first pathogenic human retrovirus to be identified.  
• 1983: Barre-Sinoussi et al (1983) discovered Human immunodeficiency virus - the 
causative agent of AIDS.  
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1.2 Retroviruses 
 
1.2.1 Structure and genome of Retroviruses (Voisset, 2000) 
 
Retroviruses are enveloped viruses with a core containing a single-stranded RNA genome of 
positive polarity. The virions are 80–100 nm in diameter. The envelope is composed of a 
lipid bilayer containing single glycopeptides. The outer envelope glycoprotein (SU) is 
responsible for receptor binding and is linked by disulphide bonds to the transmembrane 
glycoprotein (TM) which holds the SU protein in the envelope and is responsible for 
membrane fusion. Inside the envelope membrane is the rough Matrix protein (MA) that 
obscures the icosahedral capsid (CA). Inside the capsid is the core including the RNA 
genome, nucleocapsid (NC), Reverse transcriptase (RT) and, Integrase (IN) (Fig 1.1). 
 
The retrovirus genome consist of two molecules of RNA, which are single stranded, (+) sense 
and have a 5´cap and 3´poly-tail (equivalent to messenger RNA or mRNA) (Tang, Kuhen, 
and Wong-Staal, 1999). These vary in size from ∼ 8-11 kb depending upon the retroviral 
species. The two RNA molecules are physically linked by hydrogen bonds. In addition, there 
is a specific type of transfer RNA (tRNA) presented in all particles that is required for 
replication. Gene order in all retroviruses is invariant: 5´-gag-pol-env-3´. A simple retrovirus 
contains three principal genetic domains.  
1. The env gene encodes the two envelope proteins 
2. The gag (group specific antigen) gene encodes four proteins that compose the core of 
the virus.  
3. The pol (polymerase) gene encodes three enzymes in mature retroviral particles: 
• Protease that cleave the gag polyprotein into its constituent four peptides 
• Reverse transcriptase that transcribes the RNA genome into its DNA 
component 
• Integrase that catalyzes the integration of the double-stranded DNA copy into 
the host genome 
 
In addition, there are specific cis-acting sites that are important for replication such as a 
primer binding site to initiate reverse transcription, a packaging site for incorporation of 
the genome into virions, and a site for 3´polyadenylation of nascent mRNA molecules.  
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Figure 1.1: Schematic structure of a retroviral particle (Voisset, 2000) 
TM, transmembrane components; SU, surface components; IN, integrase; CA, capsid protein; MA, 
matrix protein; NC, nucleocapsid protein; RT, reverse transcriptase; PR, retroviral protease. 
  
 
1.2.2 Taxonomy of retroviruses (http://www.ncbi.nlm.nih.gov/retroviruses) 
 
Retroviruses are part of a large and diverse family of enveloped RNA viruses defined by 
common taxonomic denominators that include structure, composition, and replicative 
properties. According to the Baltimore Classification retroviruses belong to the group VI of 
viruses: Viruses with single-stramded (+) sense RNA with DNA intermediate in life cycle. 
The family Retroviridae is further subdivided into eight genera (Table 1.1).  
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Table 1.1: Taxonomy- Group VI: RNA Reverse Transcribing Viruses; Family Retroviridae (http://www.ncbi.nlm.nih.gov/retroviruses) 
Genus Type Species Genome Virion 
Morphology 
Hosts 
Alpharetrovirus Avian leucosis virus  Avian carcinoma virus 
Avian myelocytomatosis virus 
Fujinami sarcoma virus 
Rous sarcoma virus  
UR2 sarcoma virus 
Y73 sarcoma virus 
Simple central, 
spherical core 
“C particles” 
Vertebrates 
Betaretrovirus Enzootic nasal tumour virus of goats Jaagseikte sheep retrovirus 
Mason-Pfizer monkey virus 
Mouse mammary tumour virus 
Ovine enzootic nasal tumour virus 
Squirrel monkey retrovirus 
Simple Central, 
spherical core 
“B particles” 
Vertebrates 
Deltaretrovirus Bovine leukemia virus Human T-lymphotropic virus 1 
Human T-lymphotropic virus 2 
Simian T-lymphotropic virus 1 
Simian T-lymphotropic virus 2 
Simian T-lymphotropic virus 3 
Complex central, 
spherical core 
Vertebrates 
Epsilonretrovirus Walleye dermal sarcoma virus  Snakehead retrovirus Simple  Vertebrates 
Gammaretrovirus  Abelson murine leukemia virus Feline leukemia virus 
Friend murine leukernia virus  
Gibbon ape leukemia virus 
Moloney murine leukemia virus 
Moloney murine sarcoma virus 
Simple central, 
spherical core 
“C particles” 
Vertebrates 
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Murine type C retrovirus 
Porcine endogenous retrovirus 
RD114 retrovirus 
Rauscher murine leukemia virus 
Reticuloendotheliosis virus 
Spleen focus-forming virus 
Woolly monkey sarcoma virus 
Xenotropic MuLV-related virus VP62 
Lentivirus Bovine immunodeficiency virus Caprine arthritis-encephalitis virus 
Equine infectious anemia virus 
Feline immunodeficiency virus 
Human immunodeficiency virus 1  
Human immunodeficiency virus 2 
Jembrana disease virus 
Ovine lentivirus 
Simian immunodeficiency virus 
Simian immunodeficiency virus SIV-mnd 2
Simian - Human immunodeficiency virus 
Visna/Maedi virus 
Complex cone-shaped 
core 
Vertebrates 
Spumaretrovirus African green monkey simian foamy virus Bovine foamy virus 
Equine foamy virus 
Feline foamy virus 
Human foamy virus 
Human spumaretrovirus 
Simian foamy virus 
Macaque simian foamy virus 
Complex central, 
spherical core 
Vertebrates 
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1.2.3 Life cycle of retroviruses 
 
The life cycle of a retrovirus begins with specific “attachment” of retroviral particles to a 
host cell membrane, via cellular receptor and viral surface protein interactions. Some 
retroviruses also employ a secondary receptor, referred to as the co-receptor. Some retroviral 
receptors and co-receptors have been identified. For example, CD4 and various members of 
the chemokine receptor family on human T cells serve as HIV receptors and co-receptors. 
The second and third steps are “penetration” and “uncoating”, respectively. Retroviruses 
penetrate the viral envelope and fuses with the cellular plasma membrane to permit the viral 
core consisting mostly of gag-derived proteins, full-length genomic RNA, and viral enzymes 
to enter into the infected cell. The specificity of the virus-cell interaction is determined 
largely by the envelope protein of the retrovirus. The fourth step in retrovirus life-cycle is 
“replication”. Reverse transcriptase transcribes the genomic RNA into a double-stranded 
DNA molecule. The reverse transcriptase has three enzymatic activities: RNA-directed DNA 
polymerase synthesises one DNA strand, DNA-directed DNA polymerase synthesises the 
complementary strand, and RNAse H degrades the viral RNA strand. Reverse transcription is 
primed by a cellular tRNA that is packaged into retrovirus virions. After nuclear 
translocation, the genomic viral DNA is integrated in the cellular genomic DNA by the 
integrase and is then called provirus. The proviral DNA structure is composed of long 
terminal repeat (LTR) sequences located at each end of the integrated genome, surrounding 
gag, pol and env coding genes. The LTR sequences provide the transcriptional control 
elements for provirus expression.  The LTR is divided into three domains: U3 (unique 3´), R 
(repeat), and U5 (unique 5´). Since, an integrated provirus resembles other multiexon cellular 
genes it utilizes the host cell machinery for replication, expression, and protein production 
(Voisset, 2000). 
 
Following integration, the DNA genome is transcribed back into mRNA with the help of 
promoters. Transcription begins at the upstream end of the R domain and proceeds through 
the genome, terminating in a polyadenylation signal at the downstream end of the 3´ LTR. 
The U3 domain that contains basal promoters (PRO, such as a TATA box) and upstream 
enhancers (ENH) are important for retroviral transcription. The enhancers are regulatory 
elements in DNA that bind cellular proteins that act to “open” condensed DNA so that it is 
accessible to polymerase complex (Nathanson N et al., 1997). Retroviruses make use of 
splicing and ribosomal frameshifting to compress maximal information into a small genome. 
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Splicing is regulated by the cellular apparatus which interacts with cis-acting sequences 
present in the mRNA. The proteins encoded by gag, pol, and pro genes are expressed from a 
full length genomic RNA (vRNA). In Murine Leukemia virus, the pro gene is separated from 
the gag gene by terminal suppression. The env protein is expressed from a spliced mRNA. In 
more complex retrovirus (e.g., Lentivirus), several mRNAs are produced and especially the 
pattern of splicing in HIV is very complex (Tang, Kuhen, and Wong-Staal, 1999).  
 
Step five is termed “assembly” in which retrovirus capsids are assembled in an immature 
form at various locations in the host cell. The virion capsid contains two (+) RNA strands. A 
small region called the packaging signal (ϕ), spanning the 3´end of the LTR and the 5´end of 
the gag gene, mediates specific binding to the nucleocapsid protein. This is followed by an 
“egress” stage, in which after assembly of RNA and viral proteins, the virion core acquires 
the envelope protein by budding from the plasma membrane of the host. Finally, step seven is 
“maturation”. In this step, viral protease cleaves the gag-pol precursor in the core to carry 
out the maturation of virions. This step can occur along with the budding process or 
immediately after the external budding process. The progeny virions produced can initiate 
new infection cycles by binding to the receptor (s) of an appropriate target cell, entry by 
membrane fusion, and uncoating of the virion capsid virions (Voisset, 2000). Life-cycle of 
HIV is illustrated in Fig 1.2. 
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Figure 1.2: The retroviral life cycle  
(http://www.sif.it/SIF/en/portal/journals/highlight_broglia/highlight_broglia_figs) 
 
The life cycle of retroviruses can be broadly divided into six essential steps, which are shown 
schematically in the figure: The HIV enters a host cell (bind to it and inject their genes into the 
interior), copy their genes and proteins (by using the host cell's machinery and raw material), and pack 
the fresh copies into new viral particles able to spread to and infect other cells. 
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1.2.4 Genomic variation between complex versus simple retroviruses 
 
Simple retroviruses usually carry only the elementary information such as information for 
reverse transcriptase, RNase H, integrase, and protease whereas complex retroviruses code 
for additional regulatory proteins derived from multiply spliced messages. Murine leukaemia 
viruses (MuLVs) are prototype simple retroviruses, while the Human immunodeficiency virus 
(HIV-1) of the Lentivirus genus is an example for a complex retrovirus. Lentiviruses contain 
additional genes that are essential for or contributory to efficient virus replication and 
persistence. HIV-1, encodes two regulatory genes (tat, rev) and four accessory genes (vpr, 
vpu, nef, vif) that contribute to viral replication and host pathogenesis (Fig 1.3). The tat and 
rav genes are responsible for transcriptional and posttranscriptional activation of viral gene 
expression respectively (Tang, Kuhen, and Wong-Staal, 1999). 
 
 
 
 
Figure 1.3: Representative retroviral genomes of Type C retroviruses (MuLV) and lentiviruses 
(HIV-1) (Power, 2001) 
 
The figure shows the major structural genes of retroviruses (gag, pol, env), and showing the greater 
complexity of the lentiviral genomes because of the accessory genes, including rev, tat, vif, vpu, nef, 
vpr. 
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1.3 Retrovirus and host interactions 
 
Retroviruses give rise to a broad spectrum of diseases, including neurological disorders, 
malignant transformation, and immunodeficiencies such as AIDS. 
 
1.3.1 Retrovirus induced oncogenesis 
 
Most oncogenic RNA viruses belong to the family Retroviridae and the three major classes of 
oncogenic retroviruses are the nonacute transforming viruses, the acute transforming viruses, 
and the trans-acting viruses. The characteristic differences between these three classes are 
mentioned in Table 1.2.  
 
Table 1.2: Major categories of oncogenic retroviruses (Nathanson, 2001)  
 
Category Mechanism of 
transformation 
(clonality) 
Replication 
competence 
Examples 
Nonacute 
transforming  
Insertional up-
regulation of 
cellular proto-
oncogenes 
(clonal) 
Competent F-MuLV, ALV, 
FeLV 
Acute 
transforming 
Action of viral 
oncogenes 
(polyclonal) 
Defective, 
requires helper 
virus 
ASV, MSV, 
FeSV, SFFV 
Trans-acting 
transforming 
Action of viral 
accessory genes 
(oligoclonal) 
Competent HTLV-1, BLV 
 
ALV - Avian leukemia virus; ASV - avian sarcoma virus; BLV- bovine leukemia virus; FeLV 
- Feline leukemia virus; FeSV - Feline sarcoma virus; HTLV - Human T-cell leukemia virus; 
F-MuLV – Friend murine leukemia virus; SFFV – Spleen focus forming virus; MSV - 
Murine sarcoma virus. 
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1.3.2 Mechanism of Oncogenesis 
 
Tumor formation is a multistep process that in some cases could be virus-mediated and 
sometimes not. Tumor induction often requires activation of a cellular oncogene and down-
regulation of tumour suppressor genes. Each oncogenic virus tends to produce a characteristic 
range of tumors, related to the cells that it infects and the cell-specific activity of the 
enhancers in its LTR (Nathanson, 2001).  
 
 
1.3.2.1 Nonacute transforming retroviruses: Insertional mutagenesis 
 
These retroviruses have the organization of simple retroviruses, are replication competent and 
transform by promoter or enhancer insertion. Murine Leukemia viruses (MuLV), which were 
subject of research in this study, have been studied in great detail as representatives of 
nonacute transforming retroviruses. MuLV are replication-competent simple retroviruses 
which are host-specific. The DNA provirus integrates at different sites in the genome of the 
infected cell and persists for the lifetime of the specific cell type. Transformation is due to the 
effect of the LTR of the provirus upon expression of host genes. The effect can be exerted in 
two ways - promoter insertion and enhancer activation. In promoter insertion, the DNA 
provirus is integrated upstream and in the same orientation to a proto-oncogene (a normal 
cellular gene that can influence cell growth). Transcription is initiated in a LTR of the 
provirus and reads through the downstream cellular gene, increasing its rate of transcription. 
If the cellular gene that is up-regulated has an influence on cellular growth, then 
transformation may result. The resulting tumors are usually clonal but the transformed target 
cells will depend upon the genomic site of insertion (Fig 1.4a). Alternatively, for enhancer 
activation, the provirus DNA is located near a cellular gene but is oriented to read away from 
the cellular gene, the enhancer sequences in the provirus may bind cellular factors that 
“open” condensed DNA and enhance transcription of neighbouring cellular genes regardless 
of their orientation (Fig 1.4b). Again, if the gene influences cellular growth, it results in 
transformation. Hence, enhancer activation is a more common phenomenon than promoter 
insertion, as it can occur at more sites in the cellular genome (Nathanson, 2001).  
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a) 
 
  
 
 
 
 
 
 
 
 
b)  
 
 
 
 
 
 
Figure 1.4: Mechanisms of transformation (Nathanson, 2001) 
 a) Promoter insertion b) Enhancer activation  
 
 
1.3.2.2 Acute transforming Retroviruses: Viral oncogenes 
 
In these viruses, the viral genome contains a viral oncogene (v-onc) that possesses a specific 
transforming activity at a high level. Most v-onc genes were derived from proto-oncogenes 
(c-onc). Typically, acute transforming viruses are defective for replication as they have lost 
their genes such as gag and env during ancestral recombination event. Hence, they can grow 
only in the presence of a replication-competent nontransforming retrovirus. Unlike nonacute 
transforming viruses, acute transforming viruses have a shorter incubation period and 
Proto-oncogene 
DNA 
Provirus 
mRNA 
mRNA 
Enhancer 
Proto-oncogene 
DNA 
Provirus 
Promoter 
Enhancer
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transformed cells are polyclonal in nature in addition to specific tumour induction 
(Nathanson, 2001). 
 
1.3.2.3 Trans-acting retroviruses: Viral accessory genes 
 
These retroviruses encode several accessory genes which play a dual important role in viral 
replication and transformation capacity. However, the mechanism of trans-activation 
mediated oncogenesis is complex and there is also the requirement of subsequent nonviral 
genetic events for tumour induction. HTLV-1 is the best studied example in this group of 
viruses (Nathanson, 2001).  
 
 
1.4 Infection and Immunity 
 
 
Protection against infection is fundamental to the survival of all animals and is mediated by 
the immune system, comprising of both innate and adaptive mechanisms to deal with 
invading pathogens (Fig 1.5).  
 
1.4.1 Innate immunity 
 
The first line of defence against invading microbes is offered by the innate immune system 
comprising of various innate immune effector cells, including macrophages, dendritic cells 
(DCs), neutrophils and natural killer (NK) cells and various protein components of the 
complement system. Pattern-recognition receptors (PRRs), such as Toll-like receptors 
(TLRs), on the cell surface of macrophages and DCs recognize the conserved pathogen-
derived molecules or the pathogen associated molecular patterns (PAMPs). Binding of 
PAMPs to TLRs leads to production of pro-inflammatory cytokines and chemokines. The 
initial interaction of T cells with APCs is mediated by cell-adhesion molecules such as 
selectins, integrins, members of the Ig superfamily and some mucinlike molecules which help 
to attract other effector cells to the site of infection. L-selectin expressed on naïve T cells 
guides the exit of naïve T cells from the blood into peripheral lymphoid tissues.  Tissue DCs 
ingest antigens at sites of infection and are activated as part of the innate immune response 
(C.A.Janeway; Travers, 2001). 
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1.4.2 Adaptive immunity 
 
Immature dendritic cells following interaction with the antigen during innate immune 
response get activated to become mature DCs. Mature DCs have increased expression of co-
stimulatory molecules CD80 (B7.1) and CD86 (B7.2) on their surface. The receptor for B7 
molecules on the T cells is CD28, a member of immunoglobulin (Ig) superfamily like B7 
molecules. Macrophages and B cells also get activated to express B7 molecules on their 
surface. DCs, macrophages and B cells are often termed as professional antigen presenting 
cells (APCs) although DCs are much stronger APCs than macrophages and B cells.  DCs 
migrate rapidly from the periphery via afferent lymphatic channels to draining lymph nodes. 
Pathogen activated DCs present these pathogen-derived antigens to T cells and promote the 
differentiation of naive T cells to various subtypes of effector CD4+ and CD8+ T cells to 
commence the adaptive immune cascade. Peptides from intracellular pathogens that multiply 
in the cytoplasm are carried to the cell surface by MHC class I molecules and presented to 
CD8+ T cells which clonally expand in the presence of B7 molecules expressed on APCs to 
produce cytotoxic T cells (CTLs) that can kill infected target cells via production of cytotoxic 
molecules such as granzymes A and B and perforin. Peptide antigens processed from 
pathogens multiplying in intracellular vesicles and those derived from ingestion of 
extracellular bacteria and toxins are carried to the cell surface by MHC class II molecules and 
presented to CD4+ T cells which then receive a second signal from DCs provided by 
molecules of the B7 family to differentiate into helper T cells (Th), type Th1 and Th2. 
Interactions between CD28/B7.1 drive immune responses towards Th1 type while 
CD28/B7.2 favour Th2 type immune responses. CD4+ Th1 cells secrete interferon-γ (IFN-γ), 
Tumor Necrosis factor- (TNF) - α and β, which promote the anti-microbial activity of 
macrophages and helps B-cell production of IgG2a antibodies, whereas Th2 cells provide 
help for B-cell production of IgG1, IgA and IgE, which form the effector molecules of the 
humoral immune response (Janeway, 2001).  
 
Activated T cells expresses a number of accessory proteins required for sustaining co-
stimulatory signals and one such protein is CD40 ligand (CD40L), which binds to CD40 on 
APCs. Binding of CD40-CD40L triggers further activation of APCs to express more B7 
molecules, thus stimulating further T-cell proliferation. Interaction of Th cells with B cells 
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and CD8+ T cells requires ligation of CD40 (expressed on B cells and CD8+ T cells) by 
CD40L (expressed on CD4+ T cells). Activated T cells under the influence of co-stimulatory  
 
signal synthesize interleukin-2 cytokine and its receptor. IL-2 production determines whether 
a T cell will proliferate and become an armed effector cell. Antigen recognition in the 
absence of co-stimulation inactivates naïve T cells, inducing a state of anergy and the anergic 
T cells are unable to proliferate further due to the absence of IL-2. This leads to T-cell 
tolerance to the antigen and this mechanism is mostly used when self-antigens are presented 
by APCs. Some CD28-related proteins which share structural homology with CD28 such as 
CTLA-4 (CD152) when bind to B7 molecules deliver an inhibitory signal to the activated T 
cells while inducible co-stimulator (ICOS) induced on activated T cells binds to the ligand of 
ICOS (LICOS), distinct from B7 molecules and delivers an activating signal. Resolution of 
an infection is accompanied by the death of most of the effector cells to restore tissue 
integrity and the generation of long-lived memory cells. Immunological memory is the 
hallmark of adaptive immunity and is the property of remembering specific adaptive immune 
responses so as to develop a more rapid and greater response in the future to the same 
pathogen (Janeway, 2001). 
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Figure 1.5:  Immunity to infection (Mills, 2004) 
 
 
1.4.3 Helper T cells  
 
T helper (Th) cells are a subpopulation of CD4+ T cells which are specialized in providing 
supporting signals to other cell types such as macrophages, B cells and CD8+ T cells either 
through secretion of cytokines or through direct interactions to induce immunity to pathogens 
(Th cells or CD4+ T cells are used as synonym terms in this thesis unless otherwise 
mentioned). 
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1.4.3.1 Helper T cells in virus infections 
 
CD4+ T cells provide “help” to a number of key immune responses involved in controlling 
viral infections. Unlike CD8+ T cells, which are essential during the acute stages of infection, 
Th cells are found essential in controlling viral replication towards the chronic stages of 
infection. Lymphocytic choriomeningitis virus (LCMV) is a noncytopathic virus that is 
cleared primarily by CD8+CTLs. However, Th cells are required for the control of pathogenic 
strains of LCMV that can establish chronic infection in mice. Also, in the absence of CD4+ T 
cells, vaccination of mice with LCMV peptides is less effective in eliciting CTL responses 
and neutralizing antibody responses that protect against pathogenic viral challenge. When 
CD4 - deficient mice were challenged with LCMV, virus-specific CTL responses were able 
to initially control viremia, however, with time, the CD8+ CTLs lost its cyotoxic activity 
which resulted in rise in viremia. In murine influenza virus infection, viral clearance is 
antibody mediated and lack of CTLs has no effect on the control of viremia. However, 
transfer of influenza-virus specific CD4+ T cells to nude mice lacking MHC class II 
expression can induce clearance of the virus. This implies that CD4+ T cell help for B cell-
mediated production of antibodies rather than direct CD4+ T cell effector function induce 
control of influenza virus in the mouse model (Norris and Rosenberg, 2002). Vesicular 
stomatitis virus (VSV) infection of immunocompetent mice induces a rapid neutralizing IgM 
response that occurs independently of T cell help, followed by production of neutralizing IgG 
antibodies that are strictly dependent on CD4+ T cell help. The neutralizing IgG response 
seems to be crucial for recovery from primary infections and for protection against 
reinfection. Furthermore, priming of immunocompetent mice that have been primed with 
VSV rapidly eliminates a recombinant vaccinia virus expressing the VSV-G (a peptide 
derived from the glycoprotein (G) of VSV) in a CD4+ T cell-dependent manner (Maloy et al., 
1999).  
 
Viral infection is known to stimulate the production of IL-12 by DCs and macrophages, and 
is a potent inducer of Th1 responses. The successful control of vaccinia infection depends on 
the production of T cell–derived cytokines, most notably IFN-  and TNF-α by CD4+ T cells. 
In VSV infection, Th1 and Th2 cells provide different levels of anti-viral protection. Effector 
Th1 cells induced against VSV or vaccinia virus expressing the VSV-G possess much greater 
antiviral protective capacity than their Th2 counterparts. Th1 cells were able to mediate 
protection against viruses controlled by induction of IgG2a antibodies (VSV) or cytokines 
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(vaccinia). In contrast, although Th2 cells protected against systemic infection with VSV by 
inducing neutralizing IgG1 antibodies, they were unable to eradicate vaccinia virus (Maloy et 
al., 2000). Similarly, during polio virus infection in mice, Thl cells can mediate a protective 
immune response through helper activity for humoral immunity (Mahon et al., 1995).  In the 
mouse zosteriform model that mimics several aspects of reactivated HSV infection of 
humans, protective immunity could be induced routinely against zosteriform lesions caused 
by HSV. The protection is mediated by CD4+ T cells obtained from mice immunized with 
plasmid DNA-encoding glycoprotein B (gB) of HSV-1 and displayed a Th1 cytokine profile 
(Manickan et al., 1995). Acute central nervous system disease caused by Measles virus in 
Lewis rats is attenuated by transfer of individual MV protein-specific CD4+ T cells, without 
the participation of CD8+ T cells or neutralizing antibodies (Reich et al., 1992). In humans 
too, Th cells are requisite for viral clearance and resolution of disease in Hepatitis C virus 
infection. Importantly, HCV-specific Th cell responses are essential for eliminating virus 
during the acute phase of disease and these responses are also required for permanent 
maintenance of viral control. Hence, Th cells play a key role in inducing effective immune 
responses during acute viral infection and orchestrating effective immune function in chronic 
human viral infections (Altfeld and Rosenberg, 2000).   
 
1.4.3.2 Helper T cells in HIV infections 
 
The crucial importance of Th cells in immunity is dramatically demonstrated by the epidemic 
of AIDS. Activated Th cells are the main target of HIV-1 and are killed by infection and 
HIV-1 induced apoptosis. HIV-1 infection is characterized by both the absence of HIV-1 
specific Th cells and eventual decline in virus-specific CTLs, inevitably resulting in AIDS. 
Qualitative impairment of Th cell function occurs very early in the course of infection. There 
is weak proliferation of HIV-1 specific Th cells especially to the HIV whole protein in 
comparison to HIV gag protein p24, suggesting that the virus was not able to induce an 
overall strong virus-specific Th cell responses (Wahren et al., 1987). Certain other HIV 
patients displayed lower or below normal levels of lymphokine production by macrophages, 
although the antimicrobial activity of these cells were intact and when the patient’s 
monocytes were subsequently treated with exogenous IFN-γ, there was enhanced and 
effective intracellular antimicrobial activity (Murray et al., 1984). Furthermore, virus-specific 
CD8+ T cells can be maintained in the peripheral circulation at high frequency in the absence 
of circulating peripheral CD4+ T cells. However, their ability to secrete IFN-γ in response to 
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virus-specific stimulation was compromised possibly due to lack of help from CD4+ T cells 
(Spiegel et al., 2000).  
 
The ability of HIV long-term nonprogressors to control viremia is dependant on both virus-
specific Th responses and CTL responses.  In a small cohort of HIV-1-infected long-term 
nonprogressors, robust Th proliferative responses exclusively to HIV gag protein p24 
contribute to immunological control of virus replication. Anti-viral effector responses in these 
patients are mediated by increased levels of IFN-γ, the chemokine RANTES and the 
macrophage inflammatory proteins MIP-1α and MIP-1β, and no IL-4 indicating that the 
response is Th1–like (Rosenberg et al., 1997). Only HIV p24 - specific Th responses 
correlated with gag-specific CTL responses likely reflecting the immunodominance of gag 
for inducing CTL responses in chronically HIV infected patients who can control viremia. In 
the absence of Th responses, the presence of HIV-1-specific CTL was not associated with 
decreased viral replication (Kalams et al., 1999). Apart from HIV gag p24, other gag 
proteins, gp17 and gp55 also induce potent HIV-1 specific Th cell effector responses.  
 
 
1.4.4 Regulatory T cells  
 
Regulatory T cells (Treg cells) are a specialized subpopulation of T cells that act to suppress 
activation of the immune system and thereby maintain immune system homeostasis and 
tolerance to self-antigens. There are essentially two major populations of Treg cells - natural 
(or constitutive) and inducible (or adaptive) Treg cells. Natural CD4+CD25+Treg cells 
constitute 5 -10% of peripheral T cells in normal mice. Natural regulatory T cells express the 
cell-surface marker CD4, the IL-2Rα chain (CD25) and the transcriptional repressor Foxp3 
(forkhead box p3). These cells mature and migrate from the thymus and then enter peripheral 
tissues, where they suppress the activation of self-reactive T cells. On the contrary, the 
inducible regulatory T cell populations are IL-10 secreting Treg cells called TR1 and TGF-β 
secreting Treg called TH3. They are generated from naïve CD25+ or CD25- T cells in the 
periphery when they encounter antigen presented by semi-mature dendritic cells and under 
the influence of IL-10, TGF-β and possibly IFN-α. TR1 cells secrete high levels of IL-10, no 
IL-4 and very low levels of IFN-γ while TH3 cells secrete very high levels of TGF-β. In 
addition to the CD4+ Treg cells, there exists also a population of CD8+ Treg cells that secrete 
either IL-10 or TGF-β (Fig 1.6). Other rare immunosuppressors are the CD8+γδ T cells and 
the IL-10 and TGF-β-producing γδ T cells that can prevent insulin-dependent diabetes in 
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mice and suppress the anti-tumor activity of CTLs and NK cells. Furthermore, natural killer T 
cells (NKT) cells also secrete IL-10 (Mills, 2004). Natural CD4+CD25+ Treg cells were first 
defined in 1995 by Sakaguchi and colleagues. CD25, although a marker for natural regulatory 
T cells is also expressed on activated Th cells and some cells which are CD25- also have 
suppressive function. Alternative markers for Treg cells include cell-surface expression of 
CD38, CD62L, CD103 or glucocorticoid-induced tumor necrosis factor (TNF) receptor 
(GITR), CD45RBlow or intracellular expression of the transcriptional repressor Foxp3. Foxp3 
is the most unique marker of natural Treg cells. Inducible regulatory T cells are characterized 
by the cytokine production profile (IL-10 and TGF-β) rather than the expression of cell-
surface markers (Mills, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6:  Natural and Inducible regulatory T cells (Mills, 2004) 
 
 
 
1.4.4.1 Regulatory T cells in virus infections 
 
Treg cells have a key role in protection in autoimmune diseases, allograft rejection and 
allergy by suppressing potentially pathogenic immune responses mediated by effector Th1 
cells, Th2 cells or CTLs. However, during an infection, down-regulation of these very 
immune responses can have two-sided consequences –  
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a. Protective effect on the host tissues as accelerated pro-inflammatory responses could 
cause collateral tissue damage and immunoregulatory mechanisms induced by Treg are 
essential to control this immunopathology (Fig 1.7). In HCV infection, there is inhibition of 
HCV-specific T cells in chronically infected individuals by IL-10 producing CD4+ and CD8+ 
Treg cells in the liver which helps in reduce liver inflammation. HCV-infected patients with 
low numbers of CD4+CD25+ T cells often develop an autoimmune syndrome, known as 
Mixed Cryoglobulinemia, which is characterized by B-cell proliferation and autoantibody 
production. Infection of mice with Theiler’s virus induced a Demyelinating disease mediated 
by CD4+ T cells, and the transfer of CD8+ Treg cells prevented inflammation and the 
pathogenic effects of the CD4+ T cells (Mills, 2004). Furthermore, mice deprived of Treg 
cells in genital HSV-2 infection resulted in enhancement of Th1 cell responses in draining 
lymph nodes at the site of infection, but delayed the entry of the immune cells into the HSV-
infected tissue. Treg-deficient mice succumbed more rapidly, developing severe lesions and 
hind limb paralysis 4 to 5 days earlier than Treg-sufficient mice. Thus, the authors postulated 
an immune response promoting role for Tregs in acute infections in which the site of 
pathogen replication is in non-lymphoid tissues (Lund et al., 2008).  
 
 
 
 
Figure 1.7: Protective immunity by Tregs (Mills, 2004) 
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b. Immunosuppressive effect on effector T cells can also be beneficial to the virus, by 
prolonging recovery of the infected host leading to persistent infections. Many viruses 
stimulate the production of immunosuppressive cytokines for instance, IL-10 or TGF-β that 
can cause dysfunction of effector T cells (Fig 1.8). Patients with chronic HCV infection have 
circulating HCV-specific CD4+TR1 cells and CD8+ Treg cells. Blocking the anti-
inflammatory activity of Treg cells by adding neutralizing IL-10 specific antibody 
significantly increased HCV-specific IFN-γ production by effector T cells in vitro. 
Furthermore, depletion of CD4+CD25+ Treg cells from PBMCs increase the frequency of 
IFN-γ producing CD8+ and CD4+ T cells in response to CMV antigens. Removal of 
CD4+CD25+ Treg cells in HSV infected mice also increased the virus specific CD8+ T cell 
response and improved viral clearance. In EBV infected humans, induction of TR1 cells 
which are specific for LMP1 (latent membrane protein 1) of EBV inhibit TH1 cell responses 
to other EBV proteins facilitating viral persistence and promoting the induction of EBV-
associated tumors (Mills, 2004). 
c.  
 
 
Figure 1.8: Immunosuppressive activity of Tregs (Mills, 2004) 
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1.4.4.2 Regulatory T cells in retrovirus infections 
 
Retroviruses, such as HIV, which usually persist in the host for life, are potentially dangerous 
due to reactivation of the viruses in immunocompromised situations. In HIV infection, even 
before the decline in the number of CD4+ T cells begins, immune responses to HIV are 
suppressed. T cell dysfunction plays an important role in AIDS disease progression. One 
explanation for impaired T cell function arises from recent studies on Treg cells in HIV-
infected patients. Immunosuppressive CD4+ T cells, which express the common Treg marker 
CD25, and secrete immunosuppressive cytokines IL-10 and TGF-β have been shown to 
inhibit both CD4+ and CD8+ HIV-specific T cell responses. In general, IFNγ production and 
T cell proliferation were affected by Treg cells in HIV-infected patients. In addition, the 
cytotoxic activity of virus-specific CD8+ T cells was shown to be suppressed by Treg cells 
(Kinter et al., 2004). Recent results in HIV-positive patients and SIV-infected macaques 
showed that the accumulation of Treg in lymphoid tissues was associated with high HIV 
virus loads and reduced CTL activity (Andersson et al., 2005; Estes et al., 2006). It is 
assumed that viral replication and effector T cell responses may promote Treg 
compartmentalization into lymphoid organs. The question remains whether natural Treg cells 
or a population of induced Treg cells, play the major role in HIV pathogenesis and chronic 
infection. The accumulation of Treg cells in HIV-infected lymph nodes argues for an 
induction, or at least expansion, of these cells during infection. Furthermore, 
immunomodulatory proteins, such as gp120, pol, and gag from HIV stimulate IL-10 or TGF-
β production from macrophages and DC, which in addition to directly suppressing Th1 cells 
also provide the appropriate cytokine milieu for the differentiation of TR1 or TH3 cells (Mills 
and McGuirk, 2004). During FIV infection in cats, there is increased activation of 
CD4+CD25+CTLA4+ Treg cells that inhibit IL-2 production by CD4+CD25-T cells from 
normal cats. Furthermore, ablation of IL-10 secreting Treg cells in mice prevented the 
progression of murine AIDS (Nathanson, 2001). The phenotype, the mechanism of induction 
or expansion, and the interaction of Treg cells with effector T cells during retroviral infection 
need to be determined to develop therapeutic means for intervention. Demonstration of 
induced Treg cells that respond to the pathogen or pathogen-derived antigens is summarized 
in Table 1.3 and response of Natural Treg cells to pathogen is summarized in Table 1.4. 
 
 
 
Introduction 
Page | 24  
 
 
 
 
Table 1.3: Pathogen-induced regulatory T cells and their role in virus infections (Mills, 2004) 
Virus Cell type Antigen 
specific 
Cytokine 
secreted 
Responses 
suppressed 
Manipulation 
of Tregs 
Effect on immune 
response, 
immunopathology, 
and pathogen load 
Friend 
virus 
Mouse TR1 
cell 
ND IL-10 IFN-γ 
production by 
CD8+T cells  
Depletion with 
GITR-specific 
antibody 
Increases IFN-γ secreting 
CD8+T cells and reduces 
viral load (Dittmer et al., 
2004) 
Friend 
virus 
Mouse TR1 
cell 
ND ND granzyme A 
&B, perforin 
production & 
expression of 
CD107a by 
CD8+T cells 
Adoptive 
transfer of Treg 
cells 
Decreases production of 
granzymes and reduce 
expression of CD107a by 
effector CD8+T cells and 
increases viral load 
(Zelinskyy et al., 2006) 
Murine 
leukemia 
virus 
Mouse TR1 
CD4+CD25+ 
T cell 
ND IL-10 ND CD25+ T cell 
depletion 
Prevents spleen 
pathology and disease 
progression but has no 
effect on viral load 
(Beilharz et al., 2004) 
HCV Human TR1 
cell 
Yes IL-10 PBMC  IFN-
γ production 
ND ND (Brady et al., 2003; 
MacDonald et al., 2002) 
 
 
HCV Human 
CD8+ T cell 
Yes IL-10 Antigen-
specific 
PBMC 
proliferation 
 
ND ND (Accapezzato et al., 
2004) 
EBV Human TR1 
cell 
Yes IL-10 T-cell 
proliferation 
and IFN-γ 
production to 
recall antigen 
ND ND (Marshall, Vickers, 
and Barker, 2003) 
HIV Human 
CD8+ T cell 
Yes TGF-β Vaccinia 
virus specific 
CD8+T cell 
IFN-γ 
production 
ND ND (Garba et al., 2002) 
 
CD107a – degranulation marker for cytotoxic CD8+T cells; EBV - Epstein–Barr virus; GITR - 
glucocorticoid-induced tumour-necrosis factor receptor-related protein; HCV - hepatitis C virus; IFN-
γ - interferon-γ; IL-10 - interleukin-10; ND, not determined; PBMC - peripheral-blood mononuclear 
cell; TGF-β - transforming growth factor-β; Th, - T helper; TLR4 - Toll-like receptor 4; TR1 - T 
regulatory 1. 
 
 
 
 
 
Introduction 
Page | 25  
 
 
 
 
Table 1.4: Natural CD4+CD25+ Treg cells and their role in virus infections (Mills, 2004) 
 
Virus Species Antigen 
specific 
Cytokine 
secreted 
Responses 
suppressed 
Manipulation 
of Tregs 
Effect on immune 
response, 
immunopathology, 
and pathogen load 
HSV Mouse  ND IL-10 Antigen-
specific CD4+ 
T cell IFN-γ 
production 
In vivo 
depletion 
Increases Th1 cell 
responses, CD4+ T cell 
infiltration and stromal 
keratitis (Suvas et al., 
2004) 
HIV Human ND ND Antigen-
specific CD4+ 
T  and CD8+ 
T cell 
proliferation 
and cytokine 
production 
In vitro 
depletion 
Increases HIV-specific 
CD8+T cell IFN-γ 
production (Aandahl et 
al., 2004; Kinter et al., 
2004) 
 
 
 
1.5 Friend virus complex as a model to study immunity to Retroviruses 
 
One drawback in the ongoing research for HIV vaccines is the unavailability of good animal 
models. The only species that can reproducibly be infected with HIV-1 apart from humans 
are chimpanzees. However, the replication rate is really slow in these animals and it usually 
takes almost a decade to cause disease at least in some monkeys. Add to that, chimpanzee 
models have been very expensive to work with and many ethical concerns hamper large scale 
HIV vaccine experiments. An alternative to this model are macaques, which could be 
infected with Simian Immunodeficiency virus (SIV) or chimeric SIV/HIV viruses known as 
SHIVs. Since, both HIV and SIV belong to the same family of primate Lentivirus, using 
macaques have been the most crucial and good model for HIV vaccine research. However, 
there are a wide range of limitations in the approaches towards understanding the protective 
immunological mechanisms in retroviral infections. There are limited number of monkeys, 
limited knowledge about molecular immunology of monkeys, and a lack of certain 
immunological tools for studying and manipulating the macaque immune system. Mouse 
models have always been advantage over humans or other animal species in terms of 
elucidating fundamental concepts in immunology. This is because mouse models are easier to 
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handle, different immunological manipulations can be tried and mice with different genetic 
backgrounds including congenic, transgenic and knockout mice can be studied. The critical 
drawback is that both HIV and SIV cannot infect mice and hence other oncogenic murine 
retroviruses have to be considered.  Again, a large number of the known oncogenic murine 
retroviruses only induce disease in newborn and only very few of them can induce a lethal or 
semi-lethal disease in adult immunocompetent mice. Friend retrovirus is one such murine 
retrovirus and has been a useful model since past 25 years for studying the basic mechanisms 
of immunological control and escape in both acute and persistent retroviral infections 
(Dittmer and Hasenkrug, 2001). 
 
 
1.5.1 Friend virus – induced disease 
 
Friend viral erythroleukemia was discovered in 1956 by Charlotte Friend and has since 
become the model for understanding host genetic barriers to retroviral diseases. It has helped 
in identifying mouse genes that control susceptibility to virus-induced cancer and also been a 
good model for testing anti-retroviral drugs. Unlike other retroviruses that cause rapid-onset 
neoplasms Friend virus lack oncogenes and contains only retroviral-specific nucleic acid 
sequences.  Friend Virus is a complex of two viruses: Friend murine leukemia virus (F-
MuLV), a replication competent helper virus that is nonpathogenic in adult mice; and spleen 
focus-forming virus (SFFV), a replication-defective virus that is the pathogenic component 
(Kabat, 1989). SFFV cannot produce its own particles so it spreads by being packaged in F-
MuLV-encoded particles produced in cells co-infected by both viruses. SFFV unlike other 
replication defective retroviruses does not contain a viral oncogene but encodes a truncated 
form of the viral envelope glycoprotein, gp55 which associates specifically with the 
erythropoietin receptors (EpoR) at the cell surface of erythroid precursor cells (Li et al., 
1990). Binding of gp55 to EpoR leads to an increased replication of the erythroid precursors 
namely Erythropoietic Burst Formation Unit (BFU-E) and Colony forming unit-Erythroid 
(CFU-E). Erythroblastosis occurs within 48 hrs after infecting susceptible strains of mice 
with FV and the erythroblasts migrate from the bone marrow to the spleen. Following this is 
the site-specific integration of SFFV DNA near the Spi1 gene locus, which is an ets family 
transcriptional activator. The integration leads to activation of Spi1 gene and loss of tumor 
suppressor p53 (Kabat, 1989) (Fig 1.9). By 9 days post infection, erythropoietic foci cover 
the spleen which enlarges from 0.09 g to 2 - 4 g and transplantable erythroleukemia cells are 
produced as early as 15-20 days post infection (Ney and D'Andrea, 2000). Resistant strains of 
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mice are those that mount immune responses with sufficient speed and potency to prevent 
FV-induced leukemia (Hasenkrug and Dittmer, 2000). However, even the most resistant 
strains of mice are never able to completely clear virus-infected cells and develop a life-long 
chronic infection. All experiments described in this study will be performed with resistant 
mice, which do not develop acute leukemia but become chronically infected for life.  
 
 
Figure 1.9: Friend Virus-Induced Erythroleukemia in a Model Organism 
(http://www.fhcrc.org) 
 
 
1.5.1.1 Factors influencing susceptibility to FV-induced disease 
 
Susceptibility to FV-induced splenomegaly is genetically determined and controlled by 
various host genes that are important in disease induction and progression. Host genes such 
as Fv-2, Fv-5, Kit, Mgf, affect the potential of infected target cells to proliferate and 
differentiate. Fv5 determines whether FV will cause anemia or polycythemia and mutations 
in certain strains of mice (Shibuya and Mak, 1982). Mutations in Kit, Mgf genes can affect 
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normal erythropoiesis of cells (Bennett et al., 1968; Steeves et al., 1968). Fv-2 is an important 
gene locus that determines the proliferation of SFFV-infected erythroblasts since it influences 
the ability of gp55 to interact with and stimulate the erythropoietin receptor (Lilly, 1970). Fv-
2 does not interfere with retroviral entry into cells or the retroviral life cycle (Behringer and 
Dewey, 1985). Susceptibility at the Fv-2 locus (Fv-2s/s) develops lethal erythroleukemia in 
most cases. In contrast, Fv-2-resistant (Fv-2r/r) mice such as C57BL/6 and other strains are 
protected from the FV-induced disease  (Ney and D'Andrea, 2000).  
 
Fv-2 encodes a truncated form of Stk (SF-Stk), a member of the Met subfamily of receptor 
tyrosine kinases (Persons et al., 1999). Stk is closely related to RON (its human homologue), 
avian v-sea and mouse Met (Smith, Vogt, and Hayman, 1989). The susceptible phenotype, 
Fv-2s/s have increased expression of SF-Stk. Stk is the receptor for macrophage stimulating 
factor (MSP), which can induce migration of peritoneal macrophages and other cell types. 
EpoR is a member of a large family of cytokine receptors while Stk is a member of a large 
family of tyrosine kinase which may have general role as modifiers of cytokine receptor 
signaling. SF-stk is speculated to increase the affinity of EpoR-gp55 interaction or increase 
the expression of cell surface EpoR, or acts as a co-receptor that activates additional 
downstream signaling events that are required for erythroblast transformation. In addition, 
activation of Spi1 can in turn activate SF-Stk through Ets sites in the SF-Stk promoter, 
resulting in progression of FV-susceptible mice towards erythroleukemia as reviewed in (Ney 
and D'Andrea, 2000).  
 
 
1.5.1.2 Factors influencing recovery from FV-induced splenomegaly 
 
Recovery from Friend virus disease depends upon an array of genes mapped to the major 
histocompatibility complex (MHC) H-2 region of the mice. The gene locus, which influences 
the resistance of adult mice to FV-induced disease, corresponds to an allele of the H-2D 
structural gene which encodes a class I product and hence can influence the effectiveness of 
the CTL response against FV (Chesebro, Miyazawa, and Britt, 1990). H-2D region displays a 
gene-dose effect whereby H-2Db/b mice show the highest recovery incidence, H-2Db/d mice 
are intermediate, and H-2Dd/d mice are lowest. Such a gene-dose effect is probably dependent 
upon the expression levels of Db class I molecules used to present viral peptides to CTLs. H-
2A is a class II MHC gene that also help in better recovery from FV-induced disease. For H-
2A, high recovery is associated with the H-2b haplotype with a dominant effect (Chesebro, 
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Miyazawa, and Britt, 1990). The H-2Ab/b genotype or the H-2Ab/k genotype promotes CD4+ 
T-cell mediated isotype switching of FV-specific antibodies and improves responsiveness to 
vaccinia/FV envelope vaccination. While the low recovery genotypes, such as H-2Ak/k fail to 
mount T cell proliferative responses after FV infection and hence have low incidence of 
recovery (Ney and D'Andrea, 2000).  H-2E, another class II MHC gene’s effect on immunity 
to FV is more complex as it has both positive and negative effects on protection from FV 
induced disease.  H-2E molecules are not expressed on the cell surface in H-2b mice because 
of lack of a functional E α gene. However, a functional α gene can be introduced by breeding 
with mice carrying another haplotype such as H-2a. H-2a/b heterozygous mice have H-2E α 
chains from the H-2k haplotype which associates with β chains from the H-2b haplotype to 
form functional cell surface heterodimers that present F-MuLV envelope peptides to CD4+ T 
cells.   
 
In addition to the four MHC genes there is also one non MHC gene, recovery from Friend 
virus 3 (Rfv-3) gene locus. Rfv-3 is a single autosomal gene encoding a resistance trait that 
influences retroviral neutralizing antibody responses and viremia (Chesebro and Wehrly, 
1976; Chesebro and Wehrly, 1979; Doig and Chesebro, 1979). Rfv-3 is encoded by Apobec3, 
which maps to the same chromosome region as Rfv-3 and has broad inhibitory activity via 
induction of neutralizing antibodies against retroviruses, including HIV (Santiago et al., 
2008). Furthermore, there are also certain other host genes such as Fv-1, Fv-4 that interfere 
with the infection of target cells by the retrovirus. Fv-1 encodes a gag-related protein and 
interferes with the retroviral life cycle (Best et al., 1996), while, Fv-4 encodes a protein 
related to the MuLV env protein, which blocks ecotropic retroviral receptors (Ikeda et al., 
1985). Hence, to sum up, recovery from FV-induced leukemia is associated with an H-2b 
haplotype, while mice of an H-2a or H-2d haplotype, such as BALB/c, respectively readily 
succumb to the disease.  
 
 
1.5.2 Immunity to FV infection 
 
1.5.2.1 Role of cytotoxic CD8+ T cells in FV immunity 
 
Recovery from FV infection requires immunological help from all the effector arms of the 
immune system, including antibodies, CD4+ T cells and CD8+ T cells. Similar to HIV 
infections, virus titer peak quite rapidly around 7 days post infection in the acute phase then 
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drop off rapidly as immune responses develop and gain control over the infection. CD8+ T 
cells are critical for recovery from the acute phase of FV infection (Hasenkrug, Brooks, and 
Chesebro, 1995; Robertson et al., 1992) and even highly resistant mouse strains such as 
C57BL/6 fail to control acute infections in the absence of a CD8+ T cell response 
(Hasenkrug, 1999). The major viral protein recognized by CTLs in vivo is the F-MuLV env 
protein (Collins, Britt, and Chesebro, 1980). In addition, secondary CTL generated in vitro 
indicate that many FV-specific CTL were directed against the gag polyprotein of F-MuLV 
(Holt, Osorio, and Lilly, 1986; Klarnet et al., 1989). CD8+ CTL responses correlate with 
reduction of splenomegaly in FV-infected mice and the protection is mediated by IFN-γ, Fas-
FasL and cytotoxic molecules - perforin, granzymes A and B which eliminate virus-infected 
cells by apoptosis of target cells. In FV infection, the requirement for one or more of these 
molecules is dependent upon the time point of infection. During acute phase of infection, 
viral replication is controlled by the granule exocytose pathway mediated by a concerted 
action of perforin and granzyme A and B but all these three molecules can independently 
reduce viral loads. However, when all three molecules are completely absent, the mice have 
high viral loads and develop FV-induced erythroleukemia. On the contrary, Fas/FasL’s role is 
dispensable for the control of early FV replication, however, during persistent infections, 
Fas/FasL is crucial even for the high recovery mice (Zelinskyy et al., 2004). Despite recovery 
from acute viremia due to CTL responses, virus is never completely cleared in high recovery 
mice and they remain persistently infected at low levels for life.  Quite in contrast to acute FV 
infection, CD8+ T cells do not seem to have an impact on protection from chronic infection as 
depletion of CD8+ T cells in persistently infected mice has no effect on virus levels 
(Hasenkrug, Brooks, and Dittmer, 1998). Although, FV-specific CD8+ T cells expressing 
activation markers are detected in persistently infected mice, they are functionally impaired 
in their ability to produce lytic granules- perforin, granzymes A and B and also have reduced 
secretion of IFN-γ. The down-regulation of granzymes B is at the transcriptional level while 
the regulation of both perforin and granzymes A are at posttranscriptional levels indicating 
that complex regulatory mechanisms are involved in down-regulation of these effector 
molecules (Zelinskyy et al., 2005). 
 
 
1.5.2.2 Role of immunosuppressive Regulatory T cells in FV immunity 
 
The CD8+ T cells critically important during acute FV infection are rendered functionless 
during chronic FV infection. One explanation of this transition is that some form of 
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immunological escape has occurred. It is known from other infection models that escape from 
CD8+ T cells maybe mediated by poor recognition of infected cells. However, virus-specific 
CD8+ T cells from FV-specific CD8 TCR transgenic mice when transferred into persistently 
infected mice can efficiently recognise and get activated to expand clonally in response to the 
FV antigen. However, these transferred FV-specific CD8+ T cells were only able to reduce 
viral loads in acutely infected mice and not persistently infected mice even though they are 
activated and proliferative. These CD8+ T cells were functionally impaired as their ability to 
produce IFN-γ is markedly decreased in chronically infected mice. This clearly indicates 
suppression of CD8+ T cell immunity. The immunosuppressive action is brought about by 
Treg cells as when mice receive both FV-specific donor CD8+ T cells and CD4+ T cells from 
persistently infected mice, they have diminished population of IFN-γ-producing CD8+ T cells 
and increased population of host CD4+ T cells producing IL-10 (Dittmer et al., 2004). The 
glucocorticoid-induced tumour necrosis factor receptor (GITR) is associated with Treg cell 
functions (Shimizu et al., 2002). Immunosuppressive action by IL-10 secreting CD4+ T cells 
is reversed when host mice receive anti-GITR antibody along with FV-specific donor CD8+ T 
cells, and this helps to significantly decrease spleen virus levels and enhance production of 
IFN-γ and TNF-α by CD8+ T cells. Hence, in the FV model, the virus utilizes Treg cell 
system to escape CD8+ T cell responses to cause persistent infections in the host (Dittmer et 
al., 2004). The deterioration in the function of effector CD8+ T cells begins early during acute 
infection. The activation of effector CD8+ T cells is highest during the first two weeks of FV 
infection with increased production of granzymes and CD107a, a surrogate marker for 
degranulating CD8+ T cells. Subsequently, the percentage of activated CD8+ T cells starts to 
decline and also its ability to produce granzymes and CD107a. This CD8+ T cell dysfunction 
begins at the same time point as Treg cells (described by the increased expression of CD25, 
GITR, CD103, Foxp3) expanded, suggesting that early development of CD8+ T cells 
dysfunction correlates with peak expansion of Treg cells that likely contributes towards viral 
persistence (Zelinskyy et al., 2006).  
 
 
1.5.2.3 Role of B cells in FV immunity 
 
Virus-neutralizing antibodies are essential for recovery from FV infection and their 
production is influenced by a non-MHC gene, Rfv-3. Low recovery mice (H-2a/b or H-2a/a) 
with Rfv-3r/s genotype recovers from viremia via production of virus-specific antibodies that 
neutralise virus and lyse virus-infected cells in the presence of complement (Chesebro and 
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Wehrly, 1976; Chesebro and Wehrly, 1979; Doig and Chesebro, 1979). Additionally, low-
recovery mice recessive in Rfv-3 gene (Rfv-3s/s) have suppressed FV-specific antibody 
responses such as BALB/c, A/WySn and A.BY mice, fail to produce anti-FV antibodies, and 
remain viremic until death (Chesebro and Wehrly, 1976; Doig and Chesebro, 1979). 
However, in another study, near normal responses were observed in mice having the H-2a/b or 
H-2b/b genotype, whereas mice having the H-2a/a genotype were suppressed. This H-2 effect 
was observed not only in mice having heterozygous C57BL/10 × A background genes, 
including Rfv-3r/s, but also was apparent in mice having homozygous A-strain background 
genes, including Rfv-3s/s. The suppression in susceptible H-2a/a mice was characterized by a 
partial suppression of the IgM response and a profound suppression of both the primary and 
secondary IgG responses. Since, H-2a/a mice are unable to develop potent effector T cell 
responses and therefore, suppression in antibody production was probably due to the lack of 
additional T-cell help for the class switch from IgM to IgG antibodies (Morrison, Nishio, and 
Chesebro, 1986).  
 
 
1.5.2.4 Vaccine - induced protection against FV 
 
Protection from FV infection can be elicited by several different types of vaccines including 
killed and attenuated viruses, viral proteins, peptides and recombinant vaccinia vectors 
expressing FV genes. Recombinant vaccinia viruses using different combinations of FV 
epitopes, show that protective epitopes are localized to F-MuLV gag and env proteins, 
although F-MuLV env protects against infection better than gag proteins (Earl et al., 1986; 
Miyazawa, Nishio, and Chesebro, 1992). The gp70 env protein contains at least one CTL 
epitope, three Th epitopes, and two neutralizing antibody epitopes (Hasenkrug and Chesebro, 
1997). In mice immunized with the envelope vaccine, recovery from challenge with FV is 
due to induction of neutralizing antibody (IgG) and virus-specific T cell responses, thereby 
defining a protective vaccine to stimulate both CD4+ and CD8+ T cell subsets and B cells 
(Earl et al., 1986; Morrison et al., 1987). MHC background of the mice used for 
immunization plays an important role to determine the efficacy of a vaccine. Only mice that 
express MHC class-II alleles such as H-2Ab can be protected when immunized with vaccinia 
virus recombinants expressing F-MuLV env protein. MHC class-II molecules are involved in 
antigen presentation to CD4+ T cells, thereby establishing importance of CD4+ T cells in 
protective immunization (Miyazawa, Nishio, and Chesebro, 1988; Morrison et al., 1987). 
Immunization with chimeric envelope vaccines (vvCh1 vaccine)  containing only part of env 
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protein gp70 with Th cell and B cell epitopes was enough to mediate protection via CD8+ T 
cells and CD4+ T cells.  However, when the full-length Friend envelope protein (vvFr57) was 
used, protection was independent of CD8+ T cells but required CD4+ T cells for rapid 
production of virus-neutralizing antibodies which limited the viral spread in the immunized 
mice (Hasenkrug et al., 1996).  Recombinant vaccinia viruses protect mice against acute FV 
disease but not against establishment of persistent infection. Live-attenuated retroviruses 
containing attenuated N-tropic F-MuLV vaccine virus can elicit broad lymphocyte responses 
and efficient B and T cell memory and can induce complete protection against FV-induced 
splenomegaly, plasma viremia and persistent spleen infection (Dittmer, Brooks, and 
Hasenkrug, 1999a; Dittmer, Race, and Hasenkrug, 1999; Earl et al., 1986). Moreover, spleen 
cells from immunized mice when adoptively transferred into naive mice demonstrate that B 
cells and both CD4+ T cells and CD8+ T cell subsets are required to transfer protection 
against acute viremia, splenomegaly and persistent infection. Immune CD8+ T cells alone 
were not protective but could reduce viremia and facilitate recovery from FV-induced 
splenomegaly in the recipient mice. Again, CD4-depletion in recipient mice prior to CD8+ T 
cell transfer abolished the protection and this suggests the requirement of endogenous CD4+ 
T cells for CD8+ T cell – mediated protection even in the presence of transferred CD8+ T 
cells and neutralising antibodies (Dittmer, Brooks, and Hasenkrug, 1999b; Dittmer and 
Hasenkrug, 2000). In summary, from vaccination studies it is obvious that Th priming is as 
critical for retrovirus immunity as CTL priming.  
 
1.5.2.5 Role of Helper T cells in FV immunity 
 
The CD4+ T cell responses is specific for determinants in the F-MuLV env protein and two 
helper epitopes from the gp70 protein of envelope are targeted by Th cells. One peptide binds 
to H-2Ab molecules and the other to H-2E molecules, thus providing ligands for recognition 
by CD4+ T cells (Iwashiro et al., 1993; Miyazawa, Nishio, and Chesebro, 1988; Shimizu et 
al., 1994). In addition, a Th epitope has also been identified in the p15 (MA) region of F-
MuLV gag. Gag-specific CD4+ T cells are effective in controlling retrovirus infections and 
hence are potential targets for the development of effective anti-retrovirus vaccines 
(Sugahara, Tsuji-Kawahara, and Miyazawa, 2004). CD4+ T cells play very critical role in 
controlling FV replication and spread in persistently infected mice as depletion of CD4+ T 
cell subsets in these mice show a marked increase in splenomegaly. Viral loads in spleens and 
blood was much higher in CD4-depleted relapsed mice compared to non-depleted mice 
chronically infected with FV. The CD4+ T cells control viral replication during persistent 
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infections independently of CD8+ T cells and virus-neutralising antibody response 
(Hasenkrug, Brooks, and Dittmer, 1998). The mechanism of CD4+ T-cell mediated anti-viral 
effect during persistent FV infection is via production of IFN-γ. Friend virus-specific CD4+ 
T-cell clone revealed that these cells produce IFN-γ in vitro, which acts with two distinct 
mechanisms of antiviral activity. CD4+ T cells can lyse infected target cells, and they can also 
suppress virus replication by production of IFN-γ. In vivo, neutralization of IFN-γ using 
monoclonal antibodies increased the levels of virus in persistently infected mice and a 
significant percentage of IFN-gamma-deficient mice were unable to maintain long-term 
control over Friend virus infections. But, in contrast to CD4+ T-cell depletions, this was not 
sufficient to induce a relapse of splenomegaly in a significant proportion of the mice 
(Iwashiro et al., 2001). In addition, knockout mice deficient in CD4+ T cells have an 80% 
incidence of late-onset splenomegaly (Hasenkrug, 1999) while IFN-g-deficient mice have 
only a 32% incidence (Iwashiro et al., 2001). Thus, it appears that CD4+ T-cell mediated 
mechanisms in addition to IFN-γ help to control persistent FV infection. 
 
 
In summary, FV infection model is a comprehensive model to study very early events in 
retrovirus infections and also aid to understand the differences in immune responses in 
genetically diverse animals. A more defined role for CD8+ T cells in recovery from acute FV 
infection and suppression of its effector functions under the influence of Treg cells have been 
characterised. Furthermore, CD4+ T cells are known to be important in recovery from 
persistent FV infections. Additionally, CD8+ T cell, CD4+ T cell and B cell - mediated 
immune responses are critical for vaccine induced protection against persistent FV infection. 
Treg cells are responsible for dysfunction of CD8+ T cells in persistent FV infection. It will 
be important to answer the question of how important the CD4+ T cell response is for the 
control of acute virus replication and for the resistance of certain mouse strains to virus–
induced disease, which will be unravelled in the current study.  
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2. AIM & SCOPE OF WORK 
The ability to evade the host’s immune system and establish chronic infection is a feature of 
many human viruses such as retroviruses, hepatitis viruses and herpes viruses. Chronic viral 
infections lead to diseases such as AIDS, liver cancer, and severe complications in 
immunocompromised transplantation and cancer patients. Unfortunately, there is no mouse 
model available to study immune responses against HIV infections. Hence, we have used a 
murine retrovirus, namely Friend virus (FV) as a model to study basic mechanisms of 
immunological control and escape during acute retroviral infection. The role of virus-specific 
cytotoxic T cells (CTLs) is very well-characterised in the immune control of viral infections. 
However, the role of helper T cells (Th) in retroviral immunity is not well understood. The 
FV mouse model was used in the current study to characterise the anti-retroviral effector 
functions of Th cells. FV is a retroviral complex that induces lethal erythroleukemia in most 
strains of mice. Recovery from acute infection with FV is dependent upon perforin and 
granzyme-mediated cytotoxic killing of FV-infected cells by CD8-positive Cytotoxic T 
lymphocytes (CD8+CTLs). On the other hand, Th cells are known to be critical in controlling 
FV replication and spread in persistently infected mice. However, prior to this study there 
was no concrete information about the requirement of Th cells during recovery from acute 
retroviral infections.  
(C57BL/10 x A.BY) F1 mice are high recovery mice as they are able to develop potent 
immune responses against acute FV infection and do not develop lethal leukemia. However, 
they are never able to completely clear the virus and remain persistently infected for life. 
High recovery mice will be depleted of CD4+ T cells and infected with FV to study the effect 
of CD4 T cell depletion on viral replication and disease progression during an acute infection. 
CD4+ T cells are known to be important for mediating help for CD8 and B cell effector 
responses in various infectious diseases but significance of CD4 T cell help in acute retroviral 
infections remain elusive. For this purpose, FV-infected mice depleted of CD4+ T cells will 
be investigated to determine whether CD4+T cells can influence memory CD8 T cell 
responses and neutralising antibody production during acute FV infection. In humans, 
variations at immune response loci (HLA class I and II gene) determine the clinical course 
and outcome of HIV-1, HCV and HBV infections. Recovery from FV infections is also 
known to be dependent on the MHC background of mice. However, the reason for its 
differential induction of immune responses in these mice has not been investigated as yet.  
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MHC class-II tetramer technology will be used to characterize and compare the kinetics of 
CD4+ T cell responses against acute FV infection in high and intermediate recovery mice. 
Importantly, adoptive transfer experiments showed that FV-specific CD8+ T cells with an 
effector phenotype lose their protective function during chronic FV infection under the 
suppressive effect of Regulatory T (Treg) cells. We want to utilize the CD4 T-cell receptor 
(TCR) transgenic (tg) mouse model in which the CD4 TCR is specific for FV-envelope gene 
to elucidate the role of virus-specific CD4+ T cell populations in antiviral immunity in vivo. 
Since, Treg cells induce CD8 dysfunction during acute FV infection; we envisage a possible 
immunosuppressive effect of Treg cells on CD4+ T cells. For this purpose, we want to use a 
transgenic mouse model (DEREG) in which Treg cells can be specifically depleted and in 
this manner, we can analyse the effect of Treg cells on effector responses of FV-specific Th 
cells. 
Thus, our studies would help in widening our horizons on the existing knowledge on FV 
immunity by exploring the importance of Th cells during an acute retroviral infection and 
also looking at the influence of Treg cells on suppressing effector function of Th cells in vivo.   
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3.  MATERIALS   
3.1. Laboratory animals 
3.1.1 Wild-type mice  
C57BL/6 (B6)         :   Resistance genotype (H-2b/b, Fv1b/b, Fv2r/r, Rfv3r/r) 
       Harlan Winkelmann GmbH, Borchen, Germany 
  
(C57BL/10 x A.BY)F1      :   Resistance genotype (H-2b/b, Fv1b/b, Fv2r/s, Rfv3r/s), 
(Y10) Inbred at Central Animal Labor, University Hospital Essen, 
Germany 
  
(C57BL/10.A x A.BY)F1  :   Resistance genotype (H-2b/b, Fv1b/b, Fv2r/s, Rfv3r/s), 
(Y10.A) Inbred at Central Animal Labor, University Hospital Essen, 
Germany 
 
 
3.1.2. Congenic mice  
CD45.1-congenic B6         : Genotype (B6.SJL-Ptprca Pep3b/BoyJ) 
Inbred at Central Animal Labor, University Hospital Essen, 
Germany 
 
        
3.1.3. Transgenic mice  
CD4 TCRβ-transgenic (tg) mice: Created by Dr. George Kassiotis’s group (Division of 
Immunoregulation, National Institute for Medical Research, London, United Kingdom) and  
were subsequently maintained at animal facilities of University Hospital Essen.  
CD4 TCRβ-tg mice (Antunes et al., 2008) transgenically express the TCRβ chain of a TCR 
specific to an MHC class II-presented epitope of the surface (SU) product of the F-MuLV 
envelope (env) gene (Iwashiro et al., 1993). The transgenic TCRβ chain is able to associate 
with endogenous TCRα chains creating a polyclonal repertoire. 4% of peripheral CD4+ T 
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cells in CD4 TCRβ-tg mice are reactive to F-MuLV env protein. CD4 TCRβ-tg mice were 
crossed with CD45.1-congenic B6 mice for adoptive transfer experiments. 
 
DEREG mice: Created by Dr. Tim Sparwasser’s group (Institut für Medizinische 
Mikrobiologie, Immunologie und Hygiene, Technische Universität München, Munich, 
Germany) and maintained at animal facilities of University Hospital Essen.  
DEREG (depletion of regulatory T cell) mice were generated from bacterial artificial 
chromosome (BAC) technology. These mice express a diptheria toxin receptor (DTR) 
enhanced green fluorescent protein (eGFP) fusion protein under the control of the foxp3 locus. 
Usage of DEREG mice allows both detection and inducible depletion of Foxp3+ Treg cells. 
DEREG.Y10 mice were generated from crossing of DEREG mice with (H-2b/b, Fv1b/b und 
Fv2s/s 2s/bs) (A.BY) F1 mice.  
 
All mice used were sex-matched and were 8-16 weeks of age at the beginning of experiments. 
The central animal laboratory kept the mice under special pathogen-free (SPF) conditions 
which were maintained for the entire experimental phase. The mice had free access to 
drinking water and standard food. The litters of the (CD45.1-congenic B6 x CD4 TCRβ-tg 
mice) and DEREG.Y10 mice were genotyped for the expression of transgenes in 6-weeks old 
mice. DEREG.Y10 mice used for the experiments were essentially males.  
 
3.2. Virus  
The FV stock used for the experiments was a FV complex containing B-tropic  Friend 
Murine Leukemia Helper Virus (F-MuLV) and polycythemia-inducing spleen focus-forming 
virus (SFFV) (Chesebro, Miyazawa, and Britt, 1990). 
 
3.3. Cell lines 
Mus dunni cell line is susceptible to infection with FV and was used to determine the 
productivity of virus infected cells in vitro. 
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3.4. Equipment and materials 
The equipment and materials used in this study are listed in Tables 3.1 and 3.2 below. 
Table 3.1 Equipment 
Item Manufacturer 
Reflected-light microscope CK 2     Hund, Wetzlar 
Biofuge fresco Heraeus, München 
Centrifuge 5415 C Eppendorf, Hamburg 
CO2 incubator                                                  Thermo, Dreieich 
Single channel pipettes (10, 20, 100,  
200, 1000 µl)           
Eppendorf, Hamburg 
 
FACS calibur flow cytometer Becton Dickinson, Heidelberg 
Freezer LIEBHERR, Ochsenhausen 
Heating block            Grant, QBC 
Refrigerator   LIEBHERR, Ochsenhausen 
LSRII flow cytometer                                          Becton Dickinson, Heidelberg 
Megafuge 1.0R Heraeus, München 
Sorvall centrifuge fresco Thermo, Dreieich 
Laminar flow  KOJAIR®, Meckenheim 
Infrared lamps  Phillips, Amsterdam                           
Neubauer cell counting chamber                          Becton Dickinson, Heidelberg 
                                                                                                                
Table 3.2 Materials 
 
Material Manufacturer 
Beakers Schott, Mainz 
Disposable syringes (5 ml; 10 ml) B. Braun, Melsungen 
Erlenmeyer flasks Schott, Mainz 
FACS tubes  Becton Dickinson, Heidelberg 
Cannulae (G23; G25; G27) Becton Dickinson, Heidelberg 
Microtest™ cell culture plates, 96 wells Falcon BD, Heidelberg 
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Material Manufacturer 
U-shaped microplates (96 wells) Greiner bio-one, Frickenhausen 
Parafilm American National Can, Chicago 
Forceps, pointed and curved Oehmen, Essen 
Plastic pipettes (sterile; 1 ml; 5 ml; 10 ml; 25 ml) Greiner bio-one, Frickenhausen 
PP screw-cap tubes (15 ml; 50 ml) Greiner bio-one, Frickenhausen 
Reaction tubes (1,5 ml; 2 ml) Eppendorf, Hamburg 
Scissors,  large and small Oehmen, Essen 
Cell culture flasks (T25; T75; T175) Greiner bio-one, Frickenhausen 
Cell culture plates, sterile (6; 24 and 96 well) Greiner bio-one, Frickenhausen 
Cell microstrainer (70 µm) Falcon BD, Heidelberg 
 
3.5. Chemicals and media 
Unless not otherwise annotated, the following chemicals listed were procured from the 
companies Applichem, Merck, Roth and Sigma. 
 
7AAD (7-Aminoactinomycin) [Molecular Probes], AEC (3-Amino 4-Ethylencarbazole), 
Acetic acid, Ammonium chloride, Avidin-FITC [Pharmingen], Bouin´s solution, BSA 
(Bovine serum albumin), Brefeldin A, Chloroform, Cytofix/Cytoperm [BD Pharmingen], N-
N-dimethylformamide, DMSO (Dimethyl sulfoxide) DEPC, EDTA, Ethanol, Ether, Ethidium 
bromide, Formalin (40%), FCS (Fetal calf serum) [Biochrom], Foxp3 staining kit 
[eBioscience], Glucose, Guinea pig complement serum, Heparin, Hexadimethrine bromide 
(Polybrene A), Hydrochloric acid, Hydrogen peroxide, Ionomycin [CalBiochem], 
Isopropanol, LB broth base [USB], Ketamine, β-mercaptoethanol, Methyl-3H thymidine, 
OPD (o-Phenylenediamin), phenol, Picric acid, PBS [Invitrogen], PMA (Phorbol-12-Myristat 
13-Acetate), RPMI 1640 Medium [Gibco], Sodium acetate, Sodium oxide, Sodium Azide, 
Streptavidin-APC [Pharmingen], Streptavidin-FITC [Pharmingen], Streptavidin-PE 
[Pharmingen], Streptavidin-PerCP [Pharmingen], sulfuric acid, Tris-(hydroxymethyl)-
aminomethane, Trypan blue, Urea. 
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3.6. Antibiotics 
Ampicillin   (Sigma) 
Penicillin / Streptomycin (Gibco) 
 
3.7. Buffers and Media 
All solutions and buffers (unless otherwise noted) were prepared using double distilled water 
(see Table 3.3).  
 
Table  3.3 Buffers and Media 
Description Composition 
AEC working solution AEC solution was diluted 1:20 with 0.05 M sodium acetate 
and the reaction was started with 0.5 μl 30 % H2O2 / ml 
solution. 
AEC solution (4 mg/ml) AEC tablets were dissolved in N-N-dimethylformamide 
Culture medium 500 ml RPMI 1640 
10% FCS 
0.5% Penicillin/Streptomycin mixture 
Freezing mediums 40% FCS 
10% DMSO 
50% RPMI medium 
PBBS 1 l Phosphate buffered saline (PBS) 
1.0 g glucose 
MACS buffer 1 l PBS    
2mM EDTA 
0.5% BSA 
FACS buffer 1 l PBS    
0.02% Na-azide 
0.5% BSA 
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3.8. Antibodies  
Unless otherwise noted, the antibodies (AB) were procured from Becton Dickinson 
Pharmingen, Heidelberg (see Table 3.4).  
 
Table 3.4 Antibodies for flow cytometry 
 
Antibodies  Clone 
 
AK 720; monoclonal  mouse anti-MuLV env antibody (isotype IgG1)  
Horse radish peroxidase-coupled goat anti mouse immunoglobulin 
Dako] 
 
CD3e  Purified NA/LE Hamster anti-mouse antibody 145-2C11 
CD4-FITC; monoclonal rat anti-mouse antibody GK 1.5 
CD4-PE; monoclonal rat anti-mouse antibody H129.19 
CD4-PerCP; monoclonal rat anti-mouse antibody RM4-5 
CD4-APC; monoclonal rat anti-mouse antibody RM4-5 
CD4-Biotin; monoclonal rat anti-mouse antibody [eBioscience] GK 1.5 
CD4-AF700; monoclonal rat anti-mouse antibody [eBioscience] RM4-5 
CD8a-FITC; monoclonal hamster anti-mouse antibody [Caltag] 5H10 
CD8a-PerCP; monoclonal rat anti-mouse antibody [eBioscience] 53-6.7 
CD25-perCP-Cy5.5; monoclonal rat anti-mouse antibody PC61 
CD25-APC; monoclonal rat anti-mouse antibody PC61 
CD28 Purified anti-mouse antibody 37.51 
CD43-FITC monoclonal rat anti-mouse antibody 1B11 
CD43-PE ; monoclonal rat anti-mouse antibody [eBioscience] 1B11 
CD45.1-FITC, monoclonal rat anti-mouse antibody [eBioscience] A20 
CD45.1-APC, monoclonal rat anti-mouse antibody [eBioscience] A20 
CD62L-FITC; monoclonal rat anti-mouse antibody [eBioscience] MEL-14 
CD62L-APC; monoclonal rat anti-mouse antibody [eBioscience] MEL-14 
CD62L-PECy7, monoclonal rat anti-mouse antibody [eBioscience] MEL-14 
CD69-PE; monoclonal hamster anti-mouse antibody [Caltag] H1.2F3 
CD127-FITC; monoclonal rat anti-mouse antibody [eBioscience] A7R34 
CD127-PE; monoclonal rat anti-mouse antibody SB/199 
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Antibodies  Clone 
 
Fc block; Affinity purified anti-mouse CD16/CD32 93 
Foxp3- FITC; monoclonal rat anti-mouse antibody [eBioscience] FJK-16S 
Foxp3- PE; monoclonal rat anti-mouse antibody [eBioscience] NRRF30 
Foxp3- APC; monoclonal rat anti-mouse antibody [eBioscience] FJK-16S 
IFN-γ Biotin rat anti-mouse antibody [eBioscience] XMG1.2 
Mac-1-FITC; monoclonal rat anti-mouse antibody WT.5 
Mac-1-APC; monoclonal rat anti-mouse antibody WT.5 
Valpha2 TCR-FITC; monoclonal rat anti-mouse antibody  [eBioscience] B20.1 
Valpha2 TCR-PE; monoclonal rat anti-mouse antibody [eBioscience] B20.1 
 
 
 
3.9. Fluorochromes  
The antibody-coupled fluorochromes and their absorption- and emission maxima are listed in 
Table 3.5. 
 
Table 3.5 Characteristics of fluorochromes 
 
 
Flurophore Abbreviation Absorption 
(nm)  
Emission 
(nm) 
Fluorescein isothiocyanate FITC 488 518 
Phycoerythrin PE 488 575 
Peridinin-chlorophyll-protein complex  PerCP 488 675 
Phycoerythrin – Cy7 PE Cy7 488 785 
 Allophycocyanin APC 633 660 
Alexa Fluor 700  AF 700 633 723 
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3.10. Tetramers 
PE-labelled MHC class I H2-Db tetramers were custom-made from Beckman Coulters, INC, 
U.S.A. The variant peptide (ABU-ABU-L-ABU-LTVFL) loaded on the tetramers is 
recognised by DbGagL-specific CD8+ T cells (Stromnes et al., 2002). 
 
PE-labelled (I-Ab) MHC class II tetramers loaded with I-Ab-restricted MoMSV-envelope 
epitope (H19-Env) peptide-encoding (EPLTSLTPRCNTAWNRLKL) sequence. MHC class-
II tetramers were constructed by the Schumacher Laboratory (The Netherlands Cancer 
Institute, Amsterdam) and were used for the detection of I-Ab FV envelope specific CD4+ T 
cells (Schepers et al., 2002). 
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4. METHODS 
4.1.  Animal trials 
The animal experiments were conducted according to the guidelines of the Federation of 
European Laboratory Animal Science Association. 
4.2. Replication of the Friend Virus in vivo 
The FV stock was prepared as a 10% spleen cell homogenate from BALB/c mice infected 12 
days previously with 1500 spleen focus-forming units (SFFU) of uncloned virus stock. The 
spleen cell homogenate was diluted with PBBS with 2 mM EDTA and stored at -80°C. For 
the investigation of the viral concentration, Y10.A mice were infected with different dilutions 
of the spleen homogenates, and after 9 days the spleen was removed. Bouin's solution was 
used to stain the malignant cell foci on the spleen resulting from the FV infection. The 
number of these foci yielded the viral concentration in SFFU. The stock was free of 
contamination from lactate dehydrogenase virus (LDV). For the infection of the mice with 
FV the viral stock was diluted with sterile PBS. 500 µl with 6000 - 20,000 SFFU were 
injected intravenously (i.v) using a G25 cannula in a lateral tail vein of the C57BL/6 and 
DEREG mice. 
 
4.3. In vivo depletion of lymphocyte subsets 
For depletion of CD4+ T cells, Y10 mice were intraperitoneally injected with 0.5 ml of 
supernatant fluid obtained from hybridoma cell culture for CD4-specific monoclonal 
antibody (MAb) YTS 191.1. CD4 depletion was carried out using this antibody at days -6, -4, 
-2 and 0, 2 and 4 days post FV infection. Depletion of regulatory T cells was carried out in 
naïve or 3 weeks FV-infected DEREG.Y10 mice by injecting the mice with 1 µg Diphtheria 
toxin per mouse intraperitoneally on alternate days for 1 week. 
The MAb YTS191.1 was of immunoglobulin G2b isotype and was produced and used as 
ascites fluid or culture supernatant fluid.  The hybridoma cell line was a kind gift from Dr. 
Kim Hasenkrug (Laboratory of Persistent Viral Diseases, Rocky Mountain laboratories, 
NIAID, Montana, USA), and was stored in liquid Nitrogen chamber for later use.  
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4.3.1. Culturing of YTS191.1 
Principle 
CELLMAX® Artificial capillary system (Spectrum Laboratories INC. USA) was used to 
simulate an in vivo microenvironment for the cells to grow rapidly and produce a high 
amount of the desired monoclonal antibody (mAb) into a small volume of medium. In the 
CELLMAX, cells were inoculated into the extra capillary space (ECS) of the artificial 
capillary cartridge and settled onto the outer surface of the capillaries. The cells were 
subsequently nourished within this network of artificial capillaries, where nutrients and 
oxygen in the perfusing medium readily diffused through the capillary walls to nourish the 
cells. Artificial capillary cell culture, therefore, provides a three-dimensional growth 
environment in which there is cell-cell contact, rapid influx of oxygen and nutrients into the 
ECS with concomitant diffusion of metabolic waste across the capillary walls where it is 
diluted into the reservoir bottle. Secreted antibodies and other growth factors are preserved 
within the ECS thereby maintaining a stable environment similar to in vivo physiological 
conditions. 
Protocol 
The frozen anti-CD4 MAb stock was thawed and first cultured in Tissue culture (TC) flasks 
with supplemented RPMI medium. The artificial capillary module was sterilized before 
inoculating cells. The sterile reservoir cap/bottle assembly was the connected to the artificial 
capillary module. Subsequently, the cartridge was then connected to the flow path. The 
capillary system was precultured with complete growth medium (RPMI-1640 + 10% FCS + 
Pen/Strep). Only rapidly dividing cells with at least 90% viability was used. Cells to be 
inoculated were split not more than 2 days prior to inoculation. Approximately 5 x 107 cells 
were resuspended in a volume of complete RPMI slightly larger than the ECS volume of the 
cartridge. The ECS volume in the cartridge was approximately 13 ml while the flow path 
contained about 35 ml of the medium. The reservoir volume was 500 ml during initial days 
and later changed to 1000 ml. The total system volume was noted to determine the rates of 
glucose consumption as a measure of the rate of growth and medium consumption.  
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Glucose consumption rate calculations 
Quantity of glucose consumed in grams = (Vf) x (Gf) + (Vr) x (Gr) - (Vt) x (Gc)  
Where,  
Vf =  liters of fresh media at the time of previous glucose reading 
Vr =  liters of unreplaced media at the time of previous glucose reading 
Vt =  liters of total amount of media in the reservoir, tubing and the cartridge at the time of 
the current glucose reading 
Gf = glucose concentration (g/l) of fresh media 
Gr=  glucose concentration (g/l) of media at the time of previous glucose measurement 
Gr   =   glucose concentration (g/l) of fresh media at the present time 
 
The medium was replaced when the glucose concentration reached approximately 50% of the 
glucose concentration of fresh medium. Hence, fresh RPMI-1640 with a glucose 
concentration of 2.0 g/l was usually replaced in 24 hrs when its glucose concentration 
reached 1.0 to 1.5 g/l. The serum concentration in the medium was changed in a step-wise 
manner at each subsequent replacement of the medium; i.e., 10% to 7.5%, 7.5% to 5%, 5% to 
2.5%, until the lower limit of serum reduction being 1% to 2% level. If the daily glucose 
consumption rate decreased significantly subsequent to a reduction in serum, the serum 
concentration was increased to the previous level. Antibodies were harvested from the ECS 
that contained 13 ml of the medium. The cell culturing using the artificial capillary system 
was stopped when enough volume of the antibody batches were produced.  
 
4.4. Measurement of Friend virus induced splenomegaly 
Palpation for splenomegaly has been the standard protocol applied to measure the extent of 
Friend disease (Chesebro et al., 1974; Earl et al., 1986; Polsky and Lilly, 1991). Each 
infected mouse was palpated at weekly intervals under general anaesthesia and rated on a 
scale of 1+ to 4+ according to its spleen size (Fig 4.1). Normal (1+) spleen weights range from 
0.1 to 0.25 g. Spleens greater than twice normal size (more than 0.4 g) but not large enough 
to reach the ventral midline were rated as 2+. Experienced personnel can easily distinguish 
such spleens from normal spleens. Spleens large enough to reach the ventral midline were 
rated as 3+ (weight between 0.8 and 1.6 g). Spleens that extended across the abdominal 
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midline, and caused protrusion of the abdominal wall were rated as 4+ (weight greater than 
1.6 g) (Hasenkrug, K.J et al; 1998). 
 
 
Figure 4.1: FV-induced splenomegaly in (C57BL/10.A x A.BY) F1 adult mice (Hasenkrug, K.J 
et al; 1998). 
 
4.5. Preparation of single cell suspensions of spleen 
For the removal of spleens, required number of mice were anaesthetised with Isofluran® and 
killed by cervical dislocation. Spleens were collected in 6-well plates kept on ice bath. Each 
spleen was weighed and the spleen was homogenised using a sterile sieve to make single cell 
suspension of spleen cells using a sterile plunger of a 5 ml syringe. The coarser components 
were removed and the single cell suspension was transferred into a 15 ml tube. The spleen 
suspension was filled up to 10 ml with PBBS due to the high cell count. An aliquot was taken 
from each suspension to count viable cells by Trypan blue exclusion assay. The reactivity of 
trypan blue is based on the fact that the chromopore is negatively charged and does not 
interact with the cell unless the membrane is damaged. Therefore, all the cells which exclude 
the dye are viable (Fig 4.2). Aliquot was diluted with 0.4% Trypan blue stain and 10 µL of 
the diluted aliquot solution is transferred onto the Neubauer cell counting chamber and cover-
slipped to be examined under microscope (at 10x) for cell counting.  
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Figure 4.2: Illustration of viable cell counting using Trypan Blue exclusion assay.  
Grid with viable cells appear white and dead cells appear blue from the Trypan Blue dye. 
(http://www.bme.gatech.edu/vcl/Tissue_Engineering/Background/6_cell_passaging.htm) 
 
     
Formula for counting number of viable cells for the total cell concentration: 
      
 
       
 
Meanwhile, the suspensions in the tubes were centrifuged at 300 x g at 10°C for 10 minutes. 
The cell pellet was resuspended with either PBBS or RPMI medium to get a desired final 
concentration of spleen cells to be 1 x 108 cells/ml. 
 
 
4.6. MACS technology for enrichment of CD4 T-cell subset 
The Midi MACS Separation system was used for the purification of CD4+ T cells from CD4 
TCRβ-tg mice. Using the magnetic activated cell sorting (MACS) technology, spleen cells 
were labelled with super paramagnetic Micro Beads (Miltenyi Biotec) of CD4 and purified 
by immunomagentic separation on LS columns.  
Principle 
MACS® Technology is based on MACS Micro Beads, MACS Separators, and MACS 
Columns. MACS Micro Beads are super paramagnetic particles of approximately 50 
nanometers in diameter. They are composed of a biodegradable matrix, and it is therefore not 
necessary to remove them from cells after the separation process. Usually, MACS Micro  
 
Number of cells/ml = number of cells over a large square x dilution factor x 104 
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Beads do not alter structure, function, or activity status of labelled cells and are not known to 
interfere with subsequent experiments. Separation of cells using MACS technology takes 
place inside the columns. When a MACS Column is placed in a MACS Separator, a strong 
permanent magnet, a high-gradient magnetic field is induced on the column matrix which is 
enough to retain cells labeled with minimal amounts of MACS Micro Beads. Unlabelled cells 
(negative fraction) are eluted out while labeled cells (positive fraction) bound to the column 
are released after removal of the column from the magnet. Thus, with MACS Technology 
both labelled and unlabelled cell fractions can easily be isolated with high purity. The entire 
procedure of positive selection or depletion takes less than 30 minutes, and cells can 
immediately be used for further experiments (http://www.miltenyibiotec.com) (Fig 4.3). 
Single cell spleen suspensions were prepared and 1 x 108 cells/ml were stained with MACS 
CD4 microbeads and incubated for 15 minutes. The cells were washed with 10 ml of MACS 
buffer and centrifuged. During this period, LS columns were equilibrated in the magnetic 
field of the MACS separator. LS columns were washed with MACS buffer and each sample 
to be enriched for CD4+ T cell population was passed through the magnetic columns. 
Unspecific cell populations were collected as the negative fractions and CD4+ cell population 
bound to the column was then taken out of the separator to be collected separately. Positive 
fraction collected in the tubes is centrifuged and the pellets are resuspended with 1 ml PBS.  
Fraction of the samples was taken to analyse purity of the cell fractions by flow cytometry. 
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Figure 4.3: Purification of positive fraction of cells by direct magnetic labelling using MACS 
technology  
(http://www.miltenyibiotec.com) 
Step 1 
Step 2 
Step 3 
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4.7. Cultivation and storage of Mus dunni cells 
The adherent Mus dunni cells were cultivated at 37°C in a steam-saturated 5% CO2 
atmosphere and, according to the number of cells required were passaged in different cell 
culture flasks containing complete RPMI.  The cells were passaged at 95% confluence. After 
decanting the medium, the cells were washed briefly with 2 ml of 5% Trypsin-EDTA and the 
nonconfluent cells were decanted. Another 2 ml of 5% Trypsin-EDTA was added to the flask 
and incubated at 37°C for 5 min until the cells separated from the bottom of the culture flask. 
A fraction of the cells was drawn out to count the number of cells using the Trypan blue 
exclusion assay. The process was completed with a cold full medium. 1x105 cells were 
transferred from the cell suspension to a new culture flask with 10 ml fresh medium. For 
longer storage of Mus dunni cells, 1x106cells/ml were resuspended in a freezing medium. 
Aliquots of 2 ml were transferred into freeze tubes and frozen at -20°C for 2-3 hrs, stored 
overnight at -80°C and transferred into liquid nitrogen. To thaw the cells, they were heated in 
a water bath of 37°C, transferred into 10 ml of heated medium (37°C) and centrifuged for 10 
mins at 300 x g and 4°C. The pellet was rinsed again to remove the DMSO from the medium 
completely. Respectively 400 µl and 1600 µl of the cell suspension were transferred into T25 
cell culture flasks and filled up to a final volume of 10 ml. 
 
4.8. Estimation of viral loads by infectious center assay 
 
Infectious center assay (Robertson et al., 1991) was used to determine the number of 
infectious centers in the spleen which corresponded to the number of spleen focus forming 
virus per ml. Serial ten-fold dilutions of single-cell spleen suspensions (1 x 108 cells/ml) from 
FV infected mice were titrated and plated onto 6-well plates containing 2 x 104 cells of 
susceptible Mus Dunni cells in 3 ml of complete RPMI medium for each well. The plates 
were cocultivated for 3 days in the 5% CO2 incubator. 3 wells with F-MuLV and 3 wells 
without viruses or infectious cells served as control tests. In the control with F-MuLV, 
polybrene A (4 μg/ml) had to be added so that the free virus could bind better to the cell 
surfaces. Virus from the infected cells was able to infect the Mus Dunni cells via cell-cell 
contact. These replicated viruses were passed on to the daughter cells. A virus focus was 
created and each focus corresponded with one infected cell. At the end of the incubation 
period, plates were taken out from the incubator and were fixed for 5 mins with 95% ethanol 
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and subsequently rinsed with PBS and then with PBS containing 0.1% BSA.  Later, plates 
were incubated sequentially with FMuLV-envelope specific monoclonal antibody (mAb) 720 
(Robertson, M.N et al; 1991) at R.T for 1 hr. The plates were rinsed twice with PBS 
containing 0.1% BSA. The second antibody coupled with horse-radish peroxidase (goat anti 
mouse IgG1-HRP; 0.05 mol/l) was added to the plates and incubated at R.T for 1 hr during 
which the secondary antibody bound to the Fc region of the first antibody. The plates were 
washed again with PBS containing 0.1% BSA and freshly-made AEC substrate solution was 
added to each plate and incubated in darkness for 20 min at RT. The soluble substrate AEC 
converted into an insoluble red product by the HRP. The red spots marked the virus foci on 
the cell layer (Fig 4.4). Plates were then washed with running water and dried overnight to 
count the foci. The number of infectious spleen cells per mouse was calculated using the 
mean number of foci per dilution and the total count of spleen cells per mouse (Table 4.1).  
 
Figure 4.4: Viral foci in serially-diluted splenocytes co-cultivated with FV susceptible Mus dunni 
cells. 
 
Table 4.1: Calculation of Infectious centers per spleen 
Sample Cells 
(dilution) 
Foci (n) Foci/108 
cells 
 
(a) 
Total cells 
per spleen x 
108 
(b) 
ICs per 
spleen 
(Foci/108 
cells x Total 
spleen cells 
x 108 ) 
    
(a x b) 
Spleen 1 106 
 
60 
 
6000/108 2  12 x 103 foci 
in spleen 1 
105 4 
(n<10, don’t 
choose) 
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4.9. Virus-neutralizing antibody assay  
 
Mus dunni cells were plated onto 24 well plates one day prior the assay. Each row of wells 
corresponded to one sample and each well contained 7.5 x 103 cells in 2ml complete RPMI. 
The following day, polybrene was added to the Mus dunni cells. The plasma samples from 
mice were heat-inactivated at 560C water bath for 30 mins to deactivate the virus. In a 96-
well plate, an aliquot of F-MuLV stock whose concentration was previously titrated was 
added to each well in addition to guinea pig complement and serially-diluted plasma samples 
(Morrison et al., 1987). As positive controls, in 3 wells, plasma samples were replaced by 
mAb 48 with known neutralizing effect. While for negative controls, PBS instead of plasma 
sample was added to 9 wells. The plate was incubated for 370C for exactly 1 hr. Cold PBS 
was added to all the wells and a fraction of each diluted sample was added to the 
corresponding 24-well plates passaged with Mus dunni cells. All the plates were kept in the 
370 C incubator for 3 days. Cells were then fixed with ethanol and incubated sequentially 
with FMuLV-envelope specific monoclonal antibody (mAb) 720 and developed with 
secondary antibody IgG1-HRP. Viral foci were identified by developing it with AEC 
substrate. The titer was defined as the plasma dilution at which greater than 75% of the input 
virus was neutralized. 
 
4.10. Tetramers and Tetramer staining 
 
Tetramer staining has become the gold-standard method for T cell analyses and isolation of a 
very small number of antigen-specific precursor cells. A relatively new method established in 
the year 1996 by a group of eminent scientists Davis, McHeyzer-Williams and Altman was 
basically designed to tag T cells in an antigen-specific manner. Schumacher´s laboratory in 
Holland developed mouse (I-Ab) MHC class II tetramers in which the MHC heterodimers are 
expressed in conjunction with a genetically fused peptide in insect cells. In brief, 
heterodimers of the extracellular domains of the MHC class II alpha and beta chain are 
produced in insect cells with the T cell epitope covalently attached to the beta chain. Velcro 
leucine zippers are included to promote heterodimerization and a His-tag and biotinylation 
signal (bio-tag) are attached to the MHC class II alpha and beta chain respectively for 
subsequent purification and tetramer formation. Four identical biotin-containing pMHC 
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complexes are attached to fluorescently labelled streptavidin for binding to specific T cell 
receptors (TCRs) (Fig 4.5). Tetramers bind to T cells that express T cell receptors specific for 
the cognate peptide – MHC complex and can therefore be used to track Ag-specific T cells by 
flow cytometry. Although the yield of MHC class II tetramers is low as compared to MHC 
class I complexes, the resulting MHC class II tetramers stain antigen-specific CD4+ T cells in 
specific fashion. Needless to say, MHC –II tetramer positive cells are effector CD4+ T cell 
populations. 
 
 
Figure 4.5: Schematic representation of MHC class-II tetramer components 
(http://research.nki.nl/schumacherlab/MHC%20tetramers.htm) 
 
 
The (I-Ab) class-II tetramers were used for detection of I-Ab FV envelope specific CD4+ T 
cells. 1 x 106 nucleated spleen cells were incubated with PE-labelled I-Ab tetramers for 2 hrs 
at 370C and later stained with surface molecules to quantify the population of FV-specific 
activated CD4+ T cells by flow cytometry. After washing, cells were stained for APC-
labelled anti-CD4, and FITC-labelled anti-monocytes Mac-1 for 15 mins at 40C. Cells were 
washed twice, resuspended in buffer containing 7AAD and analysed by Flow cytometry and 
150,000 to 400,000 lymphocyte gated events per sample and analyses were done using BD 
Cell Quest software.  
 Methods 
Page | 56  
 
For the MHC-I staining the cells were incubated with H-2Db class-I tetramers together with 
surface markers CD8 and CD43 for 15 min at 40C. Cells were washed twice, resuspended in 
buffer containing 7AAD and analysed by Flow cytometry and 150,000 to 300,000 
lymphocyte gated events per sample and analyses were done using BD Cell Quest software.  
 
4.11. Flow cytometry 
Flow cytometry is a method to differentiate and count cells and microparticles that are tagged 
with fluorescent antibodies. Until a decade ago, the flow cytometer was seen only in research 
laboratories. Recently, it has evolved from its highly specialized research tool status to a 
commonplace clinical assay. The impetus for this change has been that flow cytometry is the 
only technique capable of quantitative measurements of multiple features of individual cells 
in a rapid manner (J. Philip McCoy, 1994). Flow cytometry is a generic term, while FACS 
(Fluorescence activated cell sorter) is a trademark of the Becton-Dickinson Corporation.  
 
4.11.1. Methodology of Flow cytometry 
  
A flow cytometer is made up of three main systems: fluidics, optics, and electronics 
(http://www.bdbiosciences.com) (Fig 4.6). 
• The fluidics system hydrodynamically focuses the cell stream to the laser beam for 
interrogation. 
• The optics system consists of lasers to illuminate the particles in the sample stream and 
optical filters to direct the resulting light signals to the appropriate detectors. 
• The electronics system converts the detected light signals into electronic signals that can be 
processed by the computer  
For some instruments equipped with a sorting feature, the electronics system is also capable 
of initiating sorting decisions to charge and deflect particles. Any suspended particle or cell 
from 0.2–150 micrometers in size is suitable for analysis. Cells from solid tissue must be 
disaggregated before analysis.  
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Figure 4.6: Principle of Flow cytometry 
(http://www.bdbiosciences.com) 
 
Light scattering 
A flow cytometer operates by causing a fluid stream to pass single file through a beam of 
light generated by a laser. The photons of light, which are disrupted and scattered and emitted 
by the cells following their interaction with the laser beam, are separated into constituent 
wavelengths by a series of filters and mirrors (J. Philip McCoy, 1994). The deflection of the 
beams depends upon impact of the laser beams on the cells and is divided into two categories. 
The light which detects the relative size of the single cells is called forward scatter (FSC) 
light, and the light which is deflected by 90° and thus reveals data about the inner granularity 
of the cells is called sideward scatter (SSC) light (http://www.bdbiosciences.com) (Fig 4.7).  
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Figure 4.7: Preliminary identification of cells based on FSC v/s SSC 
 (http://www.bdbiosciences.com) 
 
Fluorochromes 
A fluorescent compound (fluorochrome) absorbs light energy over a range of wavelengths 
that is characteristic for that compound. This absorption of light causes an electron in the 
fluorescent compound to be raised to a higher energy level. The excited electron quickly 
decays to its ground state, emitting the excess energy as a photon of light. This transition of 
energy is called fluorescence (http://www.bdbiosciences.com). These methods enable, 
amongst other things, a quantitative investigation of the surface molecules. The basis for this 
is an antigen antibody reaction conducted with fluorescently-marked antibodies which are 
aimed at particular surface molecules. The single cell suspensions are analysed by flow 
cytometry (Fig 4.8). 
 
 
 
Figure 4.8:  Specific binding of fluorochrome-labelled antibodies to cell surface antigens 
(http://www.bdbiosciences.com) 
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Signal detection 
 
Light signals are generated as particles pass through the laser beam in a fluid stream. These 
light signals are converted to electronic signals (voltages) by photodetectors and then 
assigned a channel number on a data plot. A voltage pulse is created when a particle enters 
the laser beam and starts to scatter light or fluoresce. Once the light signals, or photons, strike 
one side of the PMT or the photodiode, they are converted into a proportional number of 
electrons that are multiplied, creating a greater electrical current. The electrical current travels 
to the amplifier and is converted to a voltage pulse. The highest point of the pulse occurs 
when the particle is in the center of the beam and the maximum amount of scatter or 
fluorescence is achieved. As the particle leaves the beam, the pulse comes back down to the 
baseline (http://www.bdbiosciences.com) (Fig 4.9).  
 
 
 
Figure 4.9: Formation of a voltage pulse  
(http://www.bdbiosciences.com) 
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4.11.2. Staining of cells and FACS analyses 
 
1x106 cells from each tissue were suspended in the FACS buffer, centrifuged for 5 min with 
300 x g at RT and the supernatant was removed. The cell pellet were resuspended in 100 µl 
FACS buffer containing 0.5 - 2 µl conjugated antibodies of various surface bodies (CD4, 
CD8, CD43, CD69, CD62L, CD127, CD25, CD45.1) and incubated in the dark for 20 min at 
4°C. After a double rinse in the FACS buffer, the cells were resuspended with 400 µl FACS 
buffer. Data were acquired from 100,000 to 250,000 lymphocyte-gated events per sample.  
 
For the estimation of intracellular production of IFN-γ, spleen cells were stimulated with 
either plate-bound CD3 antibody in the presence of 2 μg/ml of CD28 antibody and 2 μg/ml of 
brefeldin A for 5 h at 370 C. The cells were then stained for surface expression of CD4, 
CD45.1 and CD43, fixed and permeabilised with Cytofix/Cytoperm solution (BD) and 
incubated with anti-mouse IFN-γ-Biotin for 30 mins at RT. Cells were washed once with 
Cytofix /Cytoperm- wash buffer and then incubated with FITC labelled Streptavidin for 30 
mins at RT. After a double rinse in the FACS buffer, the cells were resuspended in a volume 
of 400 µl with FACS buffer and analysed in detail. Data were acquired from 100,000 to 
250,000 lymphocyte-gated events per sample. Foxp3 expression was detected by intracellular 
staining using the anti-Foxp3 antibody and the Foxp3 staining set. The fluorescently-stained 
characteristics of the cells were measured on FACS Calibur and LSRII flow cytometer and 
evaluated either with Cell quest software or FlowJo software.  
 
4.11.3. Exclusion of dead cells in flow cytometry 
 
The exclusion of dead cells and cellular debris in flow cytometry was carried out using the 
dye 7-Amino-Actinomycin (7AAD). 7AAD has a high DNA binding constant and is 
efficiently excluded by intact cells. It is useful for DNA analysis and dead cell discrimination 
during flow cytometric analysis. When excited by 488 laser light, 7-AAD fluorescence is 
detected in the far red range of the spectrum (650 nm long-pass filter). In healthy cells, the 
intact cell membrane prevents the fast permeation of 7AAD and thus it is only slowly 
absorbed by the healthy cells. However, should a cell be apoptotic or is damaged or killed in 
the measuring process, then the cell membrane loses its protective function and 7AAD 
rapidly diffuses into the cell. There, it is taken up in the cell nucleus and DNA with which it 
intercalates. The cell is thus marked as “dead” and can be detected by the flow cytometer. 
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7AAD with the ratio of 1:250 was added to the stained cells in 400 µl FACS buffer and the 
sample was immediately analysed. 
 
4.12 Statistical analyses 
Statistical analyses and graphical presentations were computed with Graph Pad Prism version 
5. Statistical difference (p-value) between the different parameters was analyzed by Mann-
Whitney U test. The p-value is a probability with a value ranging from zero to one. In this 
work, all p-values ≤ 0.05 were determined significant. 
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5. RESULTS 
 
5.1. Helper T cells are important in controlling viral replication and preventing 
erythroleukemia during acute FV infections 
 
Helper T (Th) cells are important in vaccine-induced protection against FV infections 
(Dittmer and Hasenkrug, 2000) and in restricting FV replication and spread in persistently 
infected mice (Hasenkrug, Brooks, and Dittmer, 1998). What remains to be known is their 
role during acute FV infection of mice that recover from FV-induced disease. To better 
understand the importance of CD4+ T cells in recovery from acute FV infections, mice were 
injected with anti-CD4 MAbs to deplete CD4+ T cells while the control animals received PBS 
solution as mentioned in Materials and Methods (Fig 5.1). The in vivo effectiveness of the 
CD4 depletion protocol was tested. After 1 week of CD4 antibody injection, greater than 98% 
depletion of CD4+ T cells was achieved (Fig 5.2A).  One week later, CD4-depleted mice and 
non-depleted control mice were infected with a similar dose of FV. Spleens from these mice 
were palpated at weekly intervals to monitor splenomegaly (Fig 5.3A). CD4-depleted mice 
had much enlarged spleens than the non-depleted mice at 4 weeks post infection (wpi). This 
time point was therefore chosen to determine how CD4 T-cell depletions affected FV-
induced erythroleukemia and the degree of viral replication in the spleen. At 4 wpi, the levels 
of CD4+ T cells in mice depleted for CD4+ T cells was still significantly lower than in non-
depleted mice (Fig 5.2B) indicating that the effect of the CD4 depletion lasts for at least for 4 
weeks.  
 
Fig 5.1: CD4 depletion protocol 
The figure demonstrates protocol for the CD4 depletion and acute FV infection established in 
(C57BL/10 x A.BY) F1 mice. Mice were intraperitoneally injected with 0.5 ml of supernatant fluid 
obtained from hybridoma cell culture for CD4-specific mAb YTS 191.1. CD4 depletion was carried 
out at days -6, -4, -2 and 0, 2 and 4 days post FV infection. 
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Fig 5.2: Efficiency of CD4 depletion 
A) CD4 T cell depletion was performed for 1 week in (C57BL/10 x A.BY) F1 mice as described in 
Materials & Methods. Live spleen cells were isolated from a representative CD4-depleted mouse and 
a non-depleted mouse to compare percentages of total CD4+ T cells in whole lymphocyte population. 
Efficiency of CD4 depletion at 1 week post anti-CD4 treatment is demonstrated in the representative 
data from a single mouse. Percentages of positive (lower right quadrant) are given on the dot blots. B) 
Acute FV infection was established in (C57BL/10 x A.BY) F1 mice and depletion of CD4+ T cells 
was performed as described in Materials & Methods. Percentage of total CD4+ T cells in naïve (●), 
non-depleted, FV-infected (■) and CD4-depleted, FV-infected (▲) mice was determined at 4wpi. 
Each dot represents an individual mouse. Mean percentages are indicated by a line. P values were 
determined by the Mann-Whitney U test for statistical analysis and are shown in the figure. The 
experiment was repeated three times with comparable results. 
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At 4wpi, spleen weights of CD4-depleted mice ranged from 0.54 g to 4.07 g with mean 
spleen weight of 2.021 g (Fig 5.3C). This was in sharp contrast to the spleen weights of the 
non-depleted mice which had mean spleen weight of 0.21 g indicating that FV-induced 
disease had resolved by that time, almost comparable to the non-infected mice which had a 
mean spleen weight of 0.12 g (Fig 5.3C). The representative photographs of spleens from 
each group of mice clearly indicate the differences in disease progression (Fig 5.3B). These 
results suggest that the absence of CD4+ T cells affects the normal recovery from FV-induced 
disease and results in gross splenomegaly in CD4-depleted mice.  
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Fig 5.3: FV-induced splenomegaly in CD4-depleted mice 
Acute FV infection was established in (C57BL/10 x A.BY) F1 mice and depletion of CD4+ T cells 
was performed as described in Materials & Methods. A) CD4-depleted and non-depleted mice were 
palpated at weekly intervals to monitor splenomegaly and were rated on a scale of 1+ to 4+ as 
mentioned in Materials & Methods. At 4wpi, CD4-depleted mice had palpable splenomegaly in 
comparison to non-depleted mice. B) Representative photographs of spleens at 4wpi display an 
enlarged spleen from a CD4-depleted, FV-infected mouse when compared to spleens from a naïve 
mouse and non-depleted, FV-infected mouse. The spleen weights are shown below. C) Spleen 
weights of naïve (●), non-depleted, FV-infected (■) and CD4-depleted, FV-infected (▲) mice were 
determined at 4wpi.  Each dot represents an individual mouse. Mean spleen weights are indicated by a 
line. P values were determined by the Mann-Whitney U test for statistical analysis and are shown in 
the figure. The experiment was repeated three times with comparable results. 
 
 
 
Infectious center assays were performed to determine whether the absence of CD4+ T cells 
affected levels of viral replication in the spleen. Spleen cell suspensions from CD4-depleted 
and non-depleted mice were plated onto indicator cells to produce infectious centers as 
described in Materials and Methods. Infectious center assay results revealed that there were 
significantly more infectious centers in CD4-depleted mice (mean = 1.375 x 108) than in 
nondepleted mice (mean = 2.376 x 103) analysed by the Mann-Whitney U test (Fig 5.4). 
Thus, depleting the CD4 T cell population resulted in increased FV replication during acute 
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FV infection and progression of FV-induced disease from erythroproliferation to 
erythroleukemia in the resistant mouse strain (C57BL/10 x A.BY) F1. 
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Fig 5.4: CD4 depletion hampers control over virus replication  
 
Acute FV infection was established in [(C57BL/10 x A.BY) F1 mice  and depletion of CD4 T cell 
subset was performed as described in Materials & Methods. Spleen cell suspensions were plated onto 
indicator cells to produce infectious centers as described in Materials & Methods. Viral load in 
spleens of naïve (●), non-depleted, FV-infected (■) and CD4-depleted, FV-infected (▲) mice was 
determined at 4wpi.  Each dot represents an individual mouse. Mean viral loads are indicated by a 
line. P values were determined by the Mann-Whitney U test for statistical analysis and are shown in 
the figure. The experiment was repeated three times with comparable results. 
 
 
 
5.2 CD4 T cell help is needed for maintenance of FV- specific effector and memory 
CD8+ T cell responses and for the induction of neutralizing antibodies by B cells 
during acute FV infection 
 
We have established in our current study that CD4 depletions resulted in loss of immunity to 
FV infection in resistant mice. The mechanisms by which CD4+ T cells mediated protection 
against FV needed to be investigated next. CD4+ T cells are also called helper T cells (Th) as 
they coordinate various immune responses with B cells and cytotoxic CD8+ T cells. There has 
been contrasting evidence related to the requirement of help from CD4+ T cells in the 
activation, growth and survival signals in the CD8+ T cell response. Overall, primary CTL 
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responses seems to be CD4+ T-cell help independent during some infections (LCMV, 
vaccinia virus, L. monocytogenes) but help is required for the generation of long-lived 
memory CD8+ T cells to mount a stronger immune response against these pathogens during 
rechallenge. On the other hand, in other infections (adenovirus, influenza virus, HSV-1), 
primary CD8 T cell responses are dependent on CD4+ T-cell help.  Since, nothing is known 
about the significance of CD4+ T cells in mediating help to CD8+ T cells in retroviral 
infections; it was of keen interest to investigate the mode of CD4 T-cell mediated protection 
in the Friend retroviral infection model.  At 7dpi and 14dpi, FV specific effector CD8+ T cell 
responses in the spleen characterized by (CD8+CD43+Tet+ T cells) were not affected by CD4+ 
T cell depletions (Fig 5.5A). However, at 4wpi, there was a remarkable decrease in the 
population of FV specific effector CD8+ T cells in CD4-depleted mice when compared to 
non-depleted mice (Fig 5.5B). Furthermore, absolute cell numbers of FV specific effector 
memory cells characterized by (CD8+Tet+CD127+ T cells) was also significantly lower in 
CD4-depleted mice as compared to non-depleted mice (Fig 5.5C). Thus, early recovery from 
FV infections mediated by CD8+ T cell responses were CD4 T-cell help independent but 
long-term maintenance of CD8+ T cell responses required help from CD4+ T cells. 
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Fig 5.5: CD4 T-cell help is required for maintenance of FV- specific effector and memory CD8+ 
T cells during acute FV infection.  
 
Acute FV infection was established in (C57BL/10 x A.BY) F1 mice and depletion of CD4 T cells was 
performed as described in Materials & Methods. A) Spleen cells from CD4-depleted and non-depleted 
mice were isolated at 7dpi and 14dpi and stained for cell-surface CD8 and FV-specific DbgagL MHC 
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class I tetramer, and analysed by Flow cytometry. The graph shows the mean percentages ± standard 
errors of the means (SEM) of CD8+ T cells that are tetramer positive (n = 7 to 10 mice per group). 
There were no significant differences in percentage of FV-specific tetramer positive CD8+ T cell 
responses between rat Ig-injected control mice and CD4-depleted mice at both time points. (B) & (C) 
Spleen cells from CD4-depleted and non-depleted mice were isolated at 4wpi. B) Gated live CD8+ T 
cells were co-stained for the activation-associated glycoform of CD43 and FV-specific DbgagL MHC 
class I tetramer. Percentage of FV-specific effector CD8+ T cells was determined in non-depleted, FV-
infected (■) and CD4-depleted, FV-infected (▲) mice. C) Gated live CD8+ T cells were co-stained for 
FV-specific DbgagL MHC class I tetramer and CD127 to detect virus-specific memory CD8+ T cells. 
Absolute cell numbers of memory CD8+ T cells were determined in non-depleted, FV-infected (■) and 
CD4-depleted, FV-infected (▲) mice. Mean percentages for (B-C) are indicated by a line. P values 
for (A-C) were determined by the Mann-Whitney U test for statistical analysis and are shown in the 
figures. Experiments were repeated two times with comparable results. 
 
 
It is of common knowledge that CD4 T cell help is indispensable for production of 
neutralising antibodies in various infections such as HIV, Measles virus, VSV, Influenza and 
LCMV. Furthermore, virus-neutralizing antibodies are essential for recovery from FV 
infection as concluded from vaccine studies. Hence, to determine if B cells require help from 
CD4 T cells in induction of neutralising antibodies, frozen plasma samples from CD4-
depleted and non-depleted mice were tested for FV neutralising antibody levels as described 
in Materials and Methods. The mean neutralising titer for FV-infected non-depleted mice was 
1:254 while in the FV-infected mice, the mean titer was 1:44 and it was statistically different 
(Fig 5.6). Thus, helper T cells are critical for aiding B cells for induction of neutralising 
antibodies in addition to maintenance of effector memory CD8+ T cells during acute FV 
infection. 
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Fig 5.6: CD4 T cell help is required for efficient induction of neutralizing antibodies by B cells 
during acute FV infection.  
 
Acute FV infection was established in [(C57BL/10 x A.BY) F1 mice and depletion for CD4 T cell 
subset was performed as described in Materials & Methods. Frozen plasma samples from naive, CD4-
depleted and non-depleted mice were tested for neutralising antibody levels. Neutralising antibody 
titers are log2 geometric means determined by the last dilution that produced 75% F-MuLV 
neutralization (n = 6 mice per group). P values were determined by the Mann-Whitney U test for 
statistical analysis and are shown in the figure. The experiment was repeated two times with 
comparable results. 
 
 
 
Thus, in vivo depletion of Th cells in acute FV infection demonstrated that Th cells were not 
only vital in controlling viral spread and onset of erythroleukemia but also in the maintenance 
of CD8 and neutralizing antibody responses. 
 
 
5.3 Resistance to FV-induced disease correlated with the magnitude of H-2A-
restricted CD4+ T cell responses 
 
From previous work, it is known that recovery from FV-induced disease depends upon an 
array of genes mapped to the major histocompatibility complex (MHC) H-2 region of the 
mice, of which H-2A region influences effectiveness of Th cell responses. The H-2Ab/b 
genotype is associated with high recovery while the H-2Ab/k genotype is associated with 
intermediate recovery from FV infection. The H-2A genotype influences FV-specific CD4+ T 
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cell responsiveness, isotype switching of FV-specific antibodies and vaccination against FV 
(Ney and D'Andrea, 2000). Hence, we investigated how the genetic background of a mouse 
controls the protective Th cell response during acute FV infection. Therefore, we quantified 
the population of FV-specific effector CD4+ T cells taken directly ex vivo from high recovery 
(H-2Ab/b) and intermediate recovery (H-2Ab/k) mice at various time points of FV infection. 
We used tetramer technology to stain spleen cells with MHC class-II tetramers loaded with I-
Ab-restricted MoMSV-envelope epitope (H19-Env) peptide-encoding 
(EPLTSLTPRCNTAWNRLKL) sequence.  
 
 
Fig 5.7 demonstrates kinetics of FV-specific CD4+ T cell responses characterised by 
Tetramer+CD4+ T cells (CD4+Tet+ T cells) in the two different mouse strains. This kinetic 
study showed that the peak of FV-specific effector Th cell response was at 10 dpi in both 
high recovery and intermediate recovery mice which corresponded well with peak viral loads 
at 7 dpi (unpublished data). However, there was a significant difference in peak CD4+Tet+ T 
cell responses with high recovery mice having 58% more effector CD4+ T cells as compared 
to intermediate recovery mice. To corroborate if the population of CD4+Tet+ T cells had an 
effector phenotype, spleen cells were also stained for the activation markers CD43 and CD69 
at 10 dpi. Quite expectedly, CD4+ T cells from high recovery mice had significantly higher 
expression (p < 0.05) of the activation markers CD69 and CD43 in comparison to 
intermediate recovery mice (Fig 5.8). Thus, the resistance of mice to FV-induced disease 
correlated with the magnitude of the H-2A-restricted CD4+ T cell response.  
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Fig 5.7: Kinetics of FV- specific effector CD4+ T cell responses 
High recovery (H-2Ab/b) (C57BL/10 x A.BY) F1 mice and intermediate recovery (H-2Ab/k) 
(C57BL/10.A x A.BY) F1 mice were acutely infected with FV and percentages of virus-specific 
CD4+T cells reactive with I-Ab MHC class-II tetramers specific for FV-envelope epitope 
(EPLTSLTPRCNTAWNRLKL) were compared at various time points of infection. Spleen cells were 
analyzed by flow cytometry for the expression of cell surface CD4 and FV-specific MHC class-II 
tetramer. The figure shows a kinetic plot of mean percentages ± SEM of CD4+Tet+ T cells (n = 7 to 10 
mice per group). P values were determined by the Mann-Whitney U test for statistical analysis.  The 
experiment was repeated three times with comparable results.  
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Fig 5.8: Phenotypic analysis of CD4+ T cells in high and intermediate recovery mice 
 
High recovery (H-2Ab/b) (C57BL/10 x A.BY) F1 mice and intermediate recovery (H-2Ab/k) 
(C57BL/10.A x A.BY) F1 mice were acutely infected with FV for 10 days.  General levels of CD4 T-
cell activation were assessed by measuring the expression of activation markers CD69 and CD43 
gated on live CD4+ T cells. The graph shows mean percentages ± SEM of CD4+ T cells expressing 
cell surface CD69 and CD43 (n = 6 to 10 mice per group). P values were determined by the Mann-
Whitney U test for statistical analysis.  The experiment was repeated three times with comparable 
results. 
 
 
These data support the findings from vaccination experiments which established the impact 
of the genetic background of mice on FV-induced recovery. Due to the genotype H-2Ab/b, 
mice were able to develop potent immune responses against FV and recover better as 
compared to H-2Ab/k mice, which have only one H-2b allele and hence were not able to 
present antigens as effectively as high recovery mice resulting in an intermediate recovery 
from acute FV infection.   
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5.4 FV- specific CD4+ T cells produced IFN-γ production and reduced viral loads in 
FV-infected mice 
 
Although, we were able to provide sufficient evidence to state the immunoprotection by Th 
cells during acute FV infection, it would be of interest to investigate the function of 
adoptively transferred FV-specific CD4+ T cells in acute FV infection in vivo. Using 
adoptively transferred FV-specific CD8+ T cells from CD8 TCR transgenic mice, it was 
shown that such cells dramatically reduce viral loads during acute FV infection, however, fail 
to reduce viral loads in persistently infected mice (Dittmer et al., 2004). Hence, we made use 
of mice transgenically expressing the TCRβ chain of a TCR specific to an MHC class II-
presented epitope of the surface (SU) product of the F-MuLV envelope (env) gene (Antunes 
et al., 2008) to perform similar studies. 
 
Naive CD4+ T cells from CD4 TCRβ-tg mice that are specific for FV envelope were enriched 
by MidiMACS separation system and were transferred into recipient mice infected with FV 
for different time periods (Fig 5.9). Donor CD4+ T cells were differentiated from the 
endogenous host CD4+ T cells since donor and recipient mice were from a different genetic 
background. In this study, T cells from donor mice express CD45.1 while T cells from the 
recipient mice express CD45.2. Before transfer, it was verified that the phenotype of the 
isolated CD4+ T cells from CD4 TCRβ-tg mice was naïve. Donor CD4+ T cells were stained 
for activation marker CD43 and lymphocyte homing receptor CD62L for which the 
expression is high on naive cells while it is down-regulated on activated T cells. Therefore, 
the naïve phenotype was represented as CD43low and CD62Lhigh (Fig 5.10).  
 
 
Results 
Page | 75  
 
 
 
Fig 5.9: Adoptive transfer protocol 
High recovery (H-2Ab/b) (C57BL/10 x A.BY) F1 mice expressing CD45.2 were acutely infected with 
FV either for 1 week, 2 weeks or 3 weeks. 7.5 x 106 CD4+ TCRβ-tg cells from CD4 TCRβ-tg mice 
expressing CD45.1 were transferred into FV-infected recipient mice. One week after transfer, CD4+ T 
cells from recipient mice were re-isolated for ex vivo phenotype and functional analysis in the spleen.  
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Fig 5.10: Phenotype of CD4+ TCRβ-tg T cells 
Spleen cells from naïve FV-specific CD4 TCRβ-tg mice were isolated and phenotyped for surface 
expression of CD43 and CD62L by flow cytometry before being transferred into FV-infected 
Results 
Page | 76  
 
recipients. The graph shows percentage of total CD4+ TCRβ-tg T cells expressing CD43 and CD62L 
surface molecules. Each dot represents an individual mouse. Mean percentages are indicated by a line. 
The experiment was repeated three times with comparable results. 
 
 
 
One week later after adoptive transfer of CD4+ TCRβ-tg T cells into FV-infected recipient 
mice, CD4+ T cells were re-isolated and analysed by flow cytometry.  First, using this CD4 
TCRβ-tg model, phenotypic analysis of donor CD4+ T cells responding to FV were studied in 
host mice, which were infected with FV for 1, 2 or 3 weeks. Adoptive transfer of FV-specific 
TCRβ-tg CD4+ T cells into naïve control mice indicated that only poor expansion of the 
donor cells occurs when no specific antigen is present. However, a strong expansion of FV-
specific TCRβ-tg CD4+ T cells was observed after transfer into mice infected for 1, 2 or 3 
weeks (Fig 5.11A). Expansion of the donor cells was paralleled by an activation of the cells 
after recognizing their cognate antigen. Whereas very few cells that were transferred into 
naïve mice displayed an effector phenotype (CD43high and CD62Llow), the numbers of 
effector CD4+ T cells was strongly increased after transfer into infected mice. Highest 
percentages of CD4+ TCRβ tg T cells with effector phenotype were reisolated from animals 
infected with FV for 1 week, which correlated nicely with the viral loads in the recipient mice 
(Fig 5.11B). 
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Fig 5.11: Phenotype of adoptively transferred CD4+ TCRβ-tg T cells  
High recovery (H-2Ab/b) (C57BL/10 x A.BY) F1 mice expressing CD45.2 were acutely infected with 
FV either for 1 week, 2 weeks or 3 weeks. 7.5 x 106 CD4+ TCRβ-tg cells from CD4 TCRβ-tg mice 
expressing CD45.1 were transferred into FV-infected recipient mice. One week after transfer, CD4+ T 
cells from spleens of FV-infected recipient mice were re-isolated and investigated. A) Representative 
data of expansion of donor CD4+ T cells (CD45.1+ T cells) re-isolated from an individual naïve, 1, 2, 
or 3 weeks FV-infected recipient mouse. B) Mean percentages ± SEM of CD4+ TCRβ-tg T cells 
expressing CD43 and CD62L surface molecules (n = 7 mice per group). Asterisk (*) indicates that 
mean percentages ± SEM of CD4+CD43high T cells and CD4+CD62Llow T cells in 1 week FV-infected 
recipient mice was significantly higher (P < 0.05) than 2 or 3 weeks FV-infected or naïve recipient 
mice. P values were determined by the Mann-Whitney U test for statistical analysis. The experiment 
was repeated two times with comparable results. 
 
 
 
To examine the functional role of the adoptively transferred CD4+ TCRβ-tg T cells during 
acute FV infection, intracellular cytokine staining for IFN-γ was determined one week after 
transfer of CD4+ TCRβ-tg T cells transferred into mice infected for 1, 2 or 3 weeks. The 
percentage of IFN-γ producing donor CD4+ T cells in mice infected with FV for 1 or 2 weeks 
was significantly elevated in comparison to donor CD4+ T cells transferred into naïve control 
mice (Fig 5.12A and 5.12B). In contrast, transfer of FV-specific CD4+ TCRβ-tg T cells into 
mice infected with FV for 3 weeks resulted in reduction in IFN-γ producing cells (1%) in 
B 
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comparison to mice infected with FV for 1 week (15%) or 2 weeks (12.7%). Representative 
flow cytometry plots are shown in Fig 5.12A. The IFN-γ production by donor CD4+ T cells in 
3 weeks FV-infected recipient mice had declined to levels similar to that observed by donor 
CD4+ T cells transferred to naïve mice (Fig 5.12B).  
 
Fig 5.11 shows that FV-specific CD4+ TCRβ-tg T cells after transfer into mice infected with 
FV for 1, 2, or 3 weeks were substantially activated and acquired an effector phenotype in 
response to FV antigen. However, IFN-γ production was diminished in CD4+ TCRβ-tg T 
cells transferred to mice infected with FV for 3 weeks. Our group’s previous work 
demonstrate a similar dysfunction of FV specific CD8+ T cells, which although have an 
effector phenotype are unable to produce IFNγ and the cytolytic molecules perforin, 
granzyme A, and granzyme B following adoptive transfer into persistently infected mice 
(Dittmer et al., 2004; Zelinskyy et al., 2005). Hence, to quantify IFN-γ producing effector 
FV-specific CD4+ TCRβ-tg T cells in infected mice, we performed a co-staining experiment 
for IFN-γ and CD43 activation marker. A significant number of donor CD4+ T cells re-
isolated from recipient mice infected for 1 or 2 weeks had an effector phenotype and 
produced IFN-γ. Surprisingly, in spite of sufficient activation of donor CD4+ T cells re-
isolated from mice infected with FV for 3 weeks, their ability to produce IFN-γ was strongly 
reduced (Fig 5.12C). Thus, although FV-specific CD4+ T cells expanded and up-regulated 
activation marker following adoptive transfer into acutely infected mice, the cells were 
functionally impaired at 3 weeks post infection. 
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Fig 5.12: Functional analysis of adoptively transferred CD4+ TCRβ-tg T cells  
High recovery (H-2Ab/b) (C57BL/10 x A.BY) F1 mice expressing CD45.2 were acutely infected with 
FV either for 1 week (■), 2 weeks (●) or 3 weeks (♦). 7.5 x 106 CD4+ TCRβ-tg cells from CD4 
TCRβ-tg mice expressing CD45.1 were transferred into FV-infected recipient mice and naïve mice 
(□). One week after transfer, CD4+ T cells from spleens of FV-infected recipient mice were re-
isolated and intracellular IFN-γ was measured on gated donor (CD45.1) CD4+ T cells. A) IFN-γ  
production by donor FV-specific CD4+ TCRβ-tg T cells in a representative mouse. B) The graph 
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shows percentage of donor CD4+ T cells producing IFN-γ after transfer into FV-infected recipient 
mice. The mean percentages are indicated by a line. P values were determined by the Mann-Whitney 
U test for statistical analysis and are shown in the figures.  Each dot represents an individual mouse. 
C) Donor CD4+ T cells co-expressing IFNγ and CD43 in a representative mouse. (A & C) Percentages 
of positive cells (upper right quadrant) are given on the dot blots. (A-C) Experiments were repeated 
three times with comparable results. 
 
 
Given the rapid expansion and activation of the adoptively transferred CD4+ T cells in 
response to their cognate viral antigen, it was of interest to determine whether the active 
transferred cells had any effect on viral loads during acute FV infection. Furthermore, due to 
the suppression in IFN-γ production of CD4+ TCRβ-tg T cells transferred into mice infected 
with FV for 3 weeks, it was crucial to know their impact on viral replication.  At 1 week post-
transfer, the average infectious center levels in mice infected with FV for 1 week were 
reduced from 3 x 107 cells per spleen to 4 x 105 cells per spleen, a reduction of 100-fold (Fig 
5.13). Similarly, approximately 75-fold reduction in viral loads was observed in 2 weeks FV-
infected mice that received CD4+ TCRβ-tg T cells (Fig 5.13). On the contrary, CD4+ TCRβ-
tg T cells transferred into mice infected with FV for 3 weeks did not have the capacity to 
reduce viral loads in vivo (Fig 5.13).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.13: Infectious center levels after adoptive transfer of FV-specific CD4+ TCRβ-tg cells 
High recovery (H-2Ab/b) (C57BL/10 x A.BY) F1 mice expressing CD45.2 were acutely infected with 
FV either for 1 week, 2 weeks or 3 weeks. 7.5 x 106 CD4+ TCRβ-tg cells from CD4 TCRβ-tg mice 
expressing CD45.1 were transferred into FV-infected recipient mice. Spleen cell suspensions were 
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plated onto indicator cells to produce infectious centers as described in Materials & Methods. Each 
dot represents an individual mouse. The mean viral loads are indicated by a line. P values for the 
difference in means (log10) were determined by the Mann-Whitney U test for statistical analysis and 
are shown in the figures.  The experiment was repeated two times with comparable results. 
 
 
 
These results indicated that the CD4+ TCRβ-tg T cells were effective at reducing viral loads 
in mice infected with FV for 1 or 2 weeks but ineffective at reducing viral loads in 3 weeks 
FV-infected mice. Thus, although the FV-specific CD4+ T cells expanded and upregulated 
the activation marker CD43 following adoptive transfer into acutely infected mice, the cells 
were functionally impaired in mice infected with FV for 3 weeks resulting in loss of their 
anti-viral activity. 
 
 
5.5 Suppression of FV-specific CD4+ T cell responses by Regulatory T cells 
 
The functional impairment in FV-specific CD8+ T cells during chronic infection is mediated 
by CD4+ Foxp3+ regulatory T (Treg) cells, which already expand during the late phase of 
acute FV infection (2 - 3wpi) (Dittmer et al., 2004; Zelinskyy et al., 2006). In the current 
study, we speculated that the low frequency of IFNγ-producing FV-specific CD4+ T cells at 
3wpi could also be a result of CD4 T cell dysfunction by Treg cells. To determine whether 
Treg cells were inhibiting the anti-viral functions of virus-specific CD4+ T cells, we used a 
mouse model in which Foxp3 expressing Treg cells can be experimentally depleted. Injection 
of diphtheria toxin (DT) into transgenic DEREG mice (Lahl et al., 2007) that express the DT 
receptor under the control of the Foxp3 promoter can selectively deplete Foxp3+ Treg cells in 
vivo. High recovery DEREG mice expressing CD45.2 were crossed with A.BY mice and 
these F1 generation mice were termed as DEREG.Y10.  
 
Down-regulation of IFNγ responses in donor CD4+ T cells was observed in mice infected 
with FV for 3 weeks. Therefore, for the current study, naïve FV-specific CD4+TCRβ-tg CD4+ 
T cells were transferred into DEREG.Y10 mice infected with FV for 3 weeks. At the same 
time, FV-infected recipient mice also received Diphtheria toxin (DT) intraperitoneal 
injections. After 1 week posttransfer, CD4+TCRβ-tg T cells were re-isolated from FV-
infected DEREG.Y10 mice to examine the impact of Treg depletion on IFN-γ production and 
viral loads in spleen (Fig 5.14). Effectiveness of Treg depletion was assessed to verify 
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whether injection of DT at regular intervals for one week leads to selective depletion of 
Foxp3+ Treg cells in vivo. On day 7, a complete obliteration in the frequency of 
CD4+Foxp3+GFP+ Treg cells in DT-treated DEREG.Y10 mice was observed (Fig 5.15). 
Thus, Treg cells could be depleted very efficiently in DEREG.Y10 mice. However, a resident 
population of CD4+Foxp3+GFP- Treg cells was always present in all the DT-treated 
DEREG.Y10 mice in spite of different alterations in the DT treatment protocol. This was 
because not all of the Foxp3 expressing Treg cells in DEREG.Y10 mice are transgenic and 
therefore these non-transgenic CD4+Foxp3+GFP- Treg cells cannot be depleted by DT 
injection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.14: Protocol for adoptive transfer and Treg depletion with DT 
High recovery (H-2Ab/b) DEREG.Y10 mice expressing CD45.2 were acutely infected with FV for 3 
weeks. 7.5 x 106 CD4+ TCRβ-tg T cells from CD4 TCRβ-tg mice expressing CD45.1 were transferred 
into FV-infected recipient mice. Simultaneously, FV-infected DEREG.Y10 mice also received DT on 
alternate days for 1 week. 7 days posttransfer, CD4+ TCRβ-tg T cells from FV-infected mice were re-
isolated and assayed for IFN-γ production. In addition, infectious centers in the spleen were 
determined. 
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Fig 5.15: Efficiency of Treg depletion in DEREG.Y10 
 
High recovery (H-2Ab/b) DEREG.Y10 mice were injected with DT on alternate days for 1 week.  
Spleen cells were stained for intracellular Foxp3 production and gated on CD4+ T cells. Loss of Treg 
cells (CD4+Foxp3+GFP+ T cells) on day 7 in a representative DEREG.Y10 mouse treated with DT is 
shown. Percentages of CD4+Foxp3+GFP+ T cells (upper right quadrant) are given on the dot blots.  
  
 
CD4+ TCRβ-tg T cells transferred into DEREG.Y10 mice infected with FV for 3 weeks and 
treated with DT was associated with a significant rise in the percentage of IFN-γ producing 
CD4+ T cells of both host and donor origin compared to non-depleted mice (Fig 5.16A and 
5.16B). Thus, removal of Treg cells in DEREG.Y10 mice infected with FV for 3 weeks 
restored the loss in IFN-γ production by CD4+ T cells. Hence, it is clearly evident that Treg 
cells play a significant role in suppressing immune functions of Th cells in the late phase of 
acute FV infection. 
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Fig 5.16 IFN-γ production by CD4+ T cells in DT treated FV-infected DEREG.Y10 mice 
High recovery (H-2Ab/b) DEREG.Y10 mice expressing CD45.2 were acutely infected with FV for 3 
weeks. 7.5 x 106 CD4+ TCRβ-tg T cells from CD4 TCRβ-tg mice expressing CD45.1 were transferred 
into FV-infected recipient mice. Simultaneously, mice also received DT on alternate days for 1 week. 
7 days posttransfer, (A) CD4+ TCRβ-tg T cells from FV-infected mice were re-isolated from the 
spleen and assayed for IFN-γ production. The graph shows percentage of donor CD4+ T cells 
producing IFN-γ. B) The graph shows percentage of endogenous (CD45.2+) IFN-γ producing CD4+ T 
cells of the host. Each dot represents an individual mouse. The mean percentages are indicated by a 
line. P values were determined by the Mann-Whitney U test for statistical analysis and are shown in 
the figures. The experiment was repeated two times with comparable results. 
 
 
We observed that adoptively transferred CD4+ TCRβ-tg T cells into (C57BL/10 x A.BY) F1 
mice infected with FV for 3 weeks had no influence on viral loads (Fig 5.13).  Since IFN-γ 
production by CD4+ T cells was augmented following depletion of Treg cells, it was of 
interest to determine the outcome of Treg depletion on viral loads after transfer of FV-
specific CD4+ TCRβ-tg T cells. At 1 week post-transfer and DT treatment, the average 
infectious center levels in DEREG.Y10 mice infected with FV for 3 weeks were reduced 
from 1.479 x 107 per spleen to 1.194 x 104 per spleen, a reduction of approximately 1000-fold 
(Fig 5.17). Thus, Treg cells expanding during late phase of acute FV infection, down-regulate 
anti-viral functions of Th cells aiding viral replication. 
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Fig 5.17: Effect of Treg depletion on viral loads in spleen 
 
High recovery (H-2Ab/b) DEREG.Y10 mice expressing CD45.2 were acutely infected with FV for 3 
weeks. 7.5 x 106 CD4+ TCRβ-tg T cells from CD4 TCRβ-tg mice expressing CD45.1 were transferred 
into FV-infected recipient mice. Simultaneously, DEREG.Y10 mice also received DT on alternate 
days for 1 week. 7 days posttransfer, spleen cells from FV-infected mice were re-isolated from the 
spleen and assayed for viral loads. Spleen cell suspensions were plated onto indicator cells to detect 
infectious centers as described in Materials & Methods. Each dot represents an individual mouse. The 
mean viral loads are indicated by a line. P values were determined by the Mann-Whitney U test for 
statistical analysis and are shown in the figure.  Experiment was repeated two times with comparable 
results. 
 
 
 
In our current study, we established that Th cells were critical for recovery from acute Friend 
retroviral infections and CD4 T cell help was important in maintaining CD8+ T cell and 
neutralizing antibody responses. Furthermore, we also demonstrated that the magnitude of Th 
cell responses in FV resistant mice was much higher than in FV susceptible mice owing to 
the different genetic background. Adoptively transferred FV-specific Th cells were able to 
produce anti-viral IFN-γ and reduce viral loads in recipient mice. However, at 3 wpi, Th cells 
with effector phenotype lost their ability to produce IFN-γ and to control viral replication. 
Suppression in IFN-γ production by CD4+ T cells was due to the contemporaneous presence 
of Tregs which when experimentally eliminated can lead to increased antiviral activity of 
CD4+ T cells. In conclusion, we could corroborate that regulatory T cells can cause 
immunosuppression of helper T cell effector functions and contribute towards retroviral 
persistence.  
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6. DISCUSSION 
Helper T-cells (Th) represent a critical and integral part of a functional immune system and is 
well characterised in many viral infections but its role in retroviral immunity is poorly 
understood. The focus of this study was to elucidate the contribution of Th cells during acute 
FV infections in terms of recovery from FV induced disease. In vivo depletion of CD4+ T 
cells underscored the vital role of Th cells in controlling viral spread and onset of FV-induced 
erythroleukemia. High recovery (C57BL/10 x A.BY) F1 mice depleted of CD4+ T cells 
during acute FV infection were unable to recover from FV-induced splenomegaly and lethal 
leukemia. However, with increasing duration of infection, non-depleted control mice were 
able to resolve the infection and had reduced spleens unlike CD4-depleted mice, which had 
grossly enlarged spleens at that time point. This correlated with very high viral loads in CD4-
depleted mice when compared to non-depleted mice. It has been previously shown for 
persistent FV infections that depletion of CD4+ T cells resulted in a marked increase in FV-
induced disease. The viral titers from CD4-depleted persistently infected mice has been 
shown to be higher than titers from non-depleted mice. However, CD8 depletions doesn’t 
generate any relapse of FV-induced disease (Hasenkrug, Brooks, and Dittmer, 1998). Hence, 
control of persistent FV infection is CD8-independent and solely dependent upon CD4-
mediated effector responses. On the other hand, recovery from acute FV infection requires 
strong effector responses elicited by CD8-positive cytotoxic T lymphocytes (CD8+ CTLs) 
that control viral replication (Zelinskyy et al., 2004). Our results reveal that in spite of intact 
CD8+ T cell responses in acute FV infections, removal of CD4+ T cell compartment in high 
recovery mice renders them susceptible to FV-induced disease. Thus, CD4+ T cells are 
crucial for controlling FV replication during acute infections and persistent infections.   
In the current study, CD4+ T cells were also shown to be critical in maintaining CD8+ T cell 
and neutralizing antibody responses. CD4+ T cells provide “help” to a number of key immune 
responses of CD8 T cells and B cells involved in antiviral immunity. The role of CD4+ T 
cells in aiding CD8 T cell responses remain a controversial field. CD4+ T cell mediate help 
for efficient CD8 T cell responses including clonal expansion, development of effector 
function and the generation of long-term memory. However, in our current work, the absence 
of CD4 T cells during the early phase (upto 2 weeks) of acute FV infection did not influence 
the FV-specific CD8+ T cell response in FV-infected mice. Along these lines, it has been well 
documented for other murine infections of Lymphocytic choriomeningitis virus (LCMV), 
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Ectromelia virus, Vaccinia virus (VV), Listeria monocytogenes (L. monocytogenes) that CD4 
T-cell help is not needed during the priming phase of CD8+ T cell responses (Buller et al., 
1987; Janssen et al., 2003; Novy et al., 2007; Shedlock and Shen, 2003; Sun and Bevan, 
2003). This lack of requirement for CD4+ T cells during the programming phase of acute 
infection is probably because most pathogens elicit strong inflammatory stimuli to directly 
activate APCs and induce the production of inflammatory cytokines (Buller et al., 1987; Wu 
and Liu, 1994). In contrast, primary CD8 T cell responses to some pathogens such as 
Adenovirus, Influenza virus, Herpes simplex virus (HSV-1), L. monocytogenes, are dependent 
on help from CD4+ T cells (Marzo et al., 2004; Riberdy et al., 2000; Smith et al., 2004; Yang 
et al., 1995).  Interestingly, we have demonstrated here that during the late phase of acute 
infection, deficiency of CD4+ T cells in FV-infected mice affected the maintenance of FV-
specific effector CD8+ T cells. A recent work implicated that the diminished clonal expansion 
of CD8+ T cells in response to primary vaccinia virus infection in the absence of CD4+ T cells 
is caused by poor survival of activated CD8 T cells in vivo.  
Th cells are also required during the maintenance phase of the long-lived memory CD8+ T 
cell pool (Buller et al., 1987; Janssen et al., 2003; 2007; Shedlock and Shen, 2003; Sun and 
Bevan, 2003).  In line with this theory, we provided evidence that during the late acute phase 
of FV infection, mice lacking CD4+ T cells had poor expansion of FV-specific memory CD8+ 
T cells expressing the memory cell marker CD127. CD4 T-cell help provided during the 
primary response to infections like LCMV, VV, L. Monocytogenes, delivers the necessary 
“instructive signals” for the generation of fully functional memory CD8 T cells that respond 
rapidly to secondary challenge (Janssen et al., 2003; Shedlock and Shen, 2003). Furthermore, 
CD4 T-cell help is critical to sustain CD8+ CTL responses during chronic viral infection. 
Helper T-cell deficient hosts infected by persistent LCMV undergo functional deterioration 
and deletion of antiviral CD8+ T cells (Matloubian, Concepcion, and Ahmed, 1994). 
Additionally, CD8+ T cell-mediated control of chronic murine gammaherpesvirus 68 (MHV-
68) infection is eventually lost in the absence of CD4+ T cells (Cardin et al., 1996). In HIV-1 
infection, virus-specific CD8+ T cells can be maintained in the peripheral circulation at high 
frequency in the absence of circulating CD4+ T cells. However, their ability to secrete IFN-γ 
in response to virus-specific stimulation is compromised due to lack of help from CD4+ T 
cells (Spiegel et al., 2000). It needs to be further investigated in our retrovirus infection 
model whether diminished expansion of FV-specific effector CD8+ T cells was due to 
decreased survival of activated CD8+ T cells in the absence of CD4+ T cells.  In addition, 
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future studies are required to elucidate the importance of CD4 T-cell help in the generation of 
functional FV-specific memory CD8 T cells during both primary and secondary FV infection. 
Induction of anti-viral neutralizing antibodies are an important mode of defense against most 
viruses in conjunction with cellular immune responses. Lack of HIV-1 specific Th cells in 
established HIV-1 infection hampers the host’s body’s ability to generate effective antibody 
responses to the virus as reviewed in (Pantaleo, 2001). Lack of CD4 T-cell help resulted in 
significant loss of FV-specific neutralizing antibodies during acute FV infections. CD4 T-cell 
dependent humoral immune response is also essential for clearance of Influenza virus, mouse 
polyoma virus (PyV), Vesicular stomatitis virus (VSV), HSV and VV infections (Kemball et 
al., 2007; Maloy et al., 1999; Maloy et al., 2000; Manickan et al., 1995; Spriggs et al., 1992). 
Priming of multiple effector arms of the immune system including CD8, CD4 and virus-
neutralizing antibodies are vital for effective sterilizing immunity against FV (Dittmer, 
Brooks, and Hasenkrug, 1999). In this context, the requirement of all three effectors for FV 
immunity is put into perspective by our current work. It is apparent that B cell and CD8 T 
cell responses were influenced by CD4 T cell help for recovery from FV induced disease 
during acute infections, thereby strengthening the requirement of CD4 T cells in FV 
immunity. 
Recovery from FV-induced disease depends upon H-2A genotype, which influences FV-
specific CD4+ T cell responsiveness against FV (Chesebro, Miyazawa, and Britt, 1990). The 
exact mechanism of H-2A genotype associated recovery from FV is not precisely understood. 
Here we used MHC class-II tetramers to characterize and compare the kinetics of CD4+ T cell 
responses against FV in high and intermediate recovery mice. It is for the first time that FV-
specific effector Th cell responses are quantified using MHC class-II tetramer technology. 
Our study extends earlier results to show that resistance to FV-induced disease correlated 
with the magnitude of H-2A-restricted CD4+ T cell responses (Chesebro, Miyazawa, and 
Britt, 1990). Frequency of tetramer-positive CD4 T cells in high and intermediate recovery 
mice followed similar kinetics during acute FV infection. However, the magnitude of FV-
specific CD4+Tet+ T cell responses in high recovery mice was much stronger than in 
intermediate recovery mice.  This is because high recovery mice with two H-2b alleles are 
able to present more CD4 epitopes than intermediate recovery mice, which have only one H-
2b allele. In persistent PyV infection, CD4+ T-cell mediated immune responses are variable 
among allogeneic strains of inbred mice (Kemball, Szomolanyi-Tsuda, and Lukacher, 2007). 
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In other infectious diseases, like Porphyromonas gingivalis (Gemmell et al., 2002) and 
Toxoplasma gondii (Liesenfeld et al., 1996) infections, CD4 T-cell mediated immune 
responses are also shown to be dependent on MHC genes. For humans, variation at immune 
gene loci (HLA class I and II genes) determine the clinical course and outcome of HIV-1, 
HCV and HBV infections. For instance, HLA-B*27 and HLA-B*57 patients are associated 
with clearance of HCV infection and delaying AIDS while HLA-B*35 accelerates AIDS and 
HLA-DRB1*0701 is associated with HCV persistence. Additionally, HLA-A*0301 is 
associated with HBV clearance unlike HLA-B*08, which is associated with virus persistence 
as reviewed in (Martin and Carrington, 2005). Thus, strategies for vaccine development need 
to consider genetic diversity of immune response genes that can influence resistance or 
susceptibility to several different diseases.  
Previous studies have investigated the kinetics of FV-specific effector CD8+ T cells 
expansion in high recovery mice. Interestingly, peak tetramer-positive CD8 T cell responses 
is far greater in magnitude (Robertson et al., 2007; Zelinskyy et al., 2006) than peak tetramer-
positive CD4 T cell responses observed in our studies. Using class I and class II tetramers, it 
has been shown for LCMV (Homann, Teyton, and Oldstone, 2001) and Moloney murine 
sarcoma and leukemia virus complex (MoMSV) (Schepers et al., 2002) infections that the  
burst size of the virus-specific CD8+ T cell response is considerably larger (~ 20 - 40) times 
than that of virus-specific CD4+ T cells. Clonal expansion of CD8+ T cells is more profound 
than CD4+ T cells as seen in infections like HIV, Epstein-Barr virus (EBV), LCMV, 
influenza virus, Tetanus toxoid (TT). This is mainly because better expansion of CD8+ clones 
are being required to achieve efficient direct CTL killing, whereas the effects of CD4+ T cells 
are potentiated via cytokine production by these cells (Maini et al., 1999).  Moreover, clonal 
expansion of CD4+ T cells is more tightly regulated by homeostatic control molecules such as 
Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) (Chambers, Sullivan, and Allison, 1997). 
Thus, it appears that induction of CD4+ and CD8+ T-cell responses differ in both activation 
requirements and in magnitude due to their differential clonal expansion rate. 
Apart from being the “Helper” arm of the immune system, CD4+ T cells have a direct anti-
viral role in secreting cytokines such as IFN-γ and TNF-α with effector functions. IFN-γ 
production by CD4+ T cells is a key component in the control of persistent FV infection in 
mice. One additional mechanism for control of persistent FV by CD4+ T cells is possibly by 
cytolytic activity as demonstrated in vitro (Iwashiro et al., 2001b).  In the current study, we 
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investigated the anti-viral effect of FV-specific Th cell response using CD4 TCRβ transgenic 
mice (CD4 TCRβ-tg) specific for the F-MuLV envelope epitope. Quantification of adoptively 
transferred FV-specific CD4 TCRβ-tg T cells into acutely infected mice display rapid 
expansion and activation of donor T cells in response to FV antigen. Donor FV-specific 
effector CD4+ T cells displayed a rapid rise in IFN-γ levels until 2 weeks post infection. This 
correlated well with a significant reduction in viral loads in mice that received FV-specific 
CD4 TCRβ-tg T cells. Effector function of CD4+ T cells via IFN-γ production is also 
observed in Hepatitis B virus (HBV) transgenic mouse model (Franco et al., 1997). IFN-γ 
production by HIV-1 specific CD4+ T cells is associated with control of viremia in HIV-
infected individuals that did not progress to AIDS (Rosenberg et al., 1997).  However, the 
effector functions of FV-specific CD4+ T cells was lost 3 weeks post FV infection with a 
dramatic drop in the frequency of IFN-γ producing FV-specific CD4+ T cells. As a result of 
which, the adoptively transferred FV-specific CD4+ T cells were incompetent to reduce viral 
loads. Thus, although FV-specific CD4+ T cells expanded and up-regulated activation marker 
following adoptive transfer into acutely infected mice, the cells were functionally impaired at 
3 weeks post infection. A similar down-regulation in effector functions has been already 
shown for FV-specific CD8+ T cells with effector phenotype that are functionally suppressed 
during chronic FV infection. These cells fail to produce IFNγ and the cytolytic molecules 
perforin, granzyme A, and granzyme B (Dittmer et al., 2004; Zelinskyy et al., 2005), which 
are critical for the control of FV infection in resistant mice (Zelinskyy et al., 2004). 
Consequently, CD8+ T cells from chronically infected mice are unable to degranulate and kill 
FV-labelled target cells in vivo (Zelinskyy et al., 2005). 
It is interesting that although FV-specific CD8 and CD4 T cells have anti-viral effects during 
FV infection, mice are never able to completely clear the virus. During an ongoing acute 
infection, viruses adopt several strategies to evade immunesurveillance to survive in their 
host for life. Suppression of immune responses is one of the most common tactics efficiently 
used by viruses for its benefit. Measles virus infection displays inhibition of activation and 
proliferation of T cells or directly affecting their viability by means of viral proteins as 
reviewed in (Schneider-Schaulies and Dittmer, 2006). Primary SIV infection in rhesus 
monkeys also induces loss of IFN-γ and IL-2 production in CD4+ T cells, which is associated 
with both a selective depletion of memory CD4+ T cells and a loss of the functional capacity 
of the memory CD4+ T cells (Sun et al., 2007). “CD8 T cell exhaustion” is postulated as the 
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reason for loss of effector function in persistent LCMV infection (Onami et al., 2002). Our 
current work on CD4 dysfunction in acute FV infection and previous studies on CD8 
dysfunction in persistent FV infection (Dittmer et al., 2004), show that T cell dysfunction 
seem to be a common feature in many chronic viral infections.  
Immunosuppressive CD4+ Treg cells, are known as the primary mediators of peripheral 
tolerance in autoimmune diseases. However, they also limit beneficial responses by 
suppressing immune responses and limiting antitumor immunity as reviewed in (Vignali, 
Collison, and Workman, 2008). Treg cells, which express the common marker CD25 inhibit 
both HIV- specific CD4+ and CD8+ T cell responses. In general, IFNγ production and T cell 
proliferation are affected by Treg cells cells in HIV-infected patients (Aandahl et al., 2004; 
Kinter et al., 2004; Weiss et al., 2004). Evidence from studies on Hepatitis C virus (HCV) 
indicates that the expansion of CD4+CD25+ Treg cells may account for the suppression of 
effector CD8+ T cell immunity in patients with persistent viremia (Sugimoto et al., 2003).  
Other studies have also reasoned expansion of Treg cells as a strategy to suppress anti-
retroviral CTL responses (Iwashiro et al., 2001; Vahlenkamp et al., 2004; Dittmer et al., 
2004, Estes et al., 2006, Krathwohl et al. 2006). This is true for FV infections where CD4+ 
Foxp3+ Treg cells expanding during the late phase (2-3weeks) of acute FV infection 
(Zelinskyy et al., 2006) and are responsible for the functional suppression of CD8+ T cells 
observed during persistent FV infections (Dittmer et al., 2004). Interestingly, FV-infected 
dendritic cells (DC) can mediate expansion of Treg cells with immunosppressive potential. 
FV infection of DCs led to a defect in DC maturation as infected cells expressed very little 
co-stimulatory molecules. Although, naïve T cells were still activated by FV-infected DC, 
this activation did not result in antigen-specific T cell proliferation thereby inducing a state of 
tolerance rather than immunity (Balkow et al., 2007). 
 In our study, the down-regulation in IFN-γ production by FV-specific CD4+ T cells was 
observed at 3 weeks post infection, around the same time of peak expansion of Treg cells. In 
order to elucidate the role of Tregs in inhibiting CD4+ T cell responses, we used a transgenic 
mouse model, in which Treg cells can be specifically depleted (DEREG). In our current 
study, we clearly demonstrated that DEREG mice infected with FV for 3 weeks had a sharp 
augmentation in IFN-γ production by FV-specific CD4+ T cells after DT-induced depletion of 
Foxp3+ Treg cells. This correlated well with a reduction in infectious titers in the spleens of 
DT-treated DEREG mice. In contrast, a very recent paper reported that ablation of Treg cells 
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in HSV-2-infected mice resulted in an accelerated fatal infection with increased viral loads 
instead of enhanced immunity to the virus (Lund et al., 2008). The authors also used a mouse 
model in which they could deplete Treg cells by DT injection. Depletion of Treg cells 
amplified the immune responses in draining lymph nodes at the site of infection, but delayed 
the entry of the immune cells into the HSV-infected tissue. Thus, the authors postulated an 
immune response promoting role for Treg cells in acute infections in which the site of 
pathogen replication is in non-lymphoid tissues. In contrast to these findings, our study using 
FV-infected DEREG mice provide first experimental evidence that Treg cells were directly 
involved in suppression of anti-viral CD4+ T cell responses during an acute retroviral 
infection. The suppressive activity of Treg cells on antiviral immunity is the predominant 
effect in viral infections in which the primary targets of the virus are cells of the lymphoid 
organs. This suggests that the predominant biological effect of Treg cells in different viral 
infections can be quite diverse ranging from boosting to suppressing anti-viral immune 
responses and it depends on the site of viral replication.  
Although, the concept of immunosuppressive Treg cells came into being three decades ago, 
the precise mechanisms underlying Treg-mediated suppression remain elusive. Several 
mechanisms of suppression have been proposed and one of the mechanism is via production 
of immunosuppressive cytokines such as Interleukin-10 (IL-10) and Transforming growth 
factor (TGF-β). In autoimmune diseases, effector functions of T cells are inhibited by IL-10 
and TGF-β by blocking the maturation and activation of dendritic cells (DCs) or other 
antigen presenting cells (APCs) as reviewed in (Vignali, Collison, and Workman, 2008). IL-
10 and TGF-β secreted by CD25+CD4+ Treg cells suppresses IFN-γ production by effector T 
cells in HIV-infected individuals (Kinter et al., 2004; Weiss et al., 2004). In chronic FV 
infection, the generation of class I restricted CTL activity was suppressed in vitro by additive 
actions of TGF-β and CTLA-4 expressed on Treg cells (Iwashiro et al., 2001a). A second 
mechanism used by Treg cells is by inducing cytolysis of effector T cells. For instance, naïve 
CD4+ CD45RA+ cells of human origin when stimulated in vitro with specific antibodies can 
also develop into Treg cells with cytolytic potential. These cells can kill B cells, NK cells and 
CTLs in a granzyme-B-dependent and perforin-dependent manner resulting in the 
suppression of crucial immune responses (Grossman et al., 2004). Additionally, activated 
Treg cells can induce apoptosis of effector T cells in vitro and in vivo through a TRAIL-DR5 
(tumor-necrosis-factor-related apoptosis-inducing ligand-death receptor 5) pathway (Ren et 
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al., 2007) and also via up-regulation of galectin-1 (Garin et al., 2007). Another mechanism of 
apoptosis-mediated suppression is by metabolic disruption of effector T cells induced by Treg 
cells via IL-2 deprivation mediated apoptosis. Treg cells compete with T cells for 
consumption of growth and/or survival factors such as IL-2. Treg cells deprives effector T 
cells of IL-2 leading to the death of effector cells and this mode of suppression can be 
observed in vitro (Pandiyan et al., 2007). However, in vivo work using human Treg cells 
suggest that IL-2 depletion alone cannot render apoptosis of effector T cells since they are not 
exclusively dependent on IL-2 for its proliferation (Oberle et al., 2007). A third mechanism 
for Treg-mediated suppression is through expression of the ectoenzymes CD39 and CD73 by 
Tregs. Concordant expression of CD39 and CD73 catalyzes the production of pericellular 
adenosine, which resulted in suppression of  effector T cell function through activation of the 
adenosine receptor 2A (Borsellino et al., 2007; Deaglio et al., 2007; Kobie et al., 2006).  
A fourth mechanism of suppression is through direct interaction of Treg cells with effector T 
cells via gap junctions. Natural Treg cells harbor high levels of cyclic adenosine 
monophosphate (cAMP), a potent inhibitor of T cell proliferation and IL-2 synthesis. Treg 
cells suppress effector T cell function directly by transferring the potent cAMP into responder 
T cells through membrane gap junctions (Bopp et al., 2007). A cell-to-cell contact dependent 
Treg-mediated suppression in vitro was also demonstrated for FV infection. CD4+CD25+ T 
cells isolated from mice chronically infected with FV can suppress IFN-γ production by 
activated CD8+ T cells in a direct cell-to-cell contact dependent manner in the absence of 
APCs (Robertson et al., 2006). Furthermore, FV induced Treg cells express Connexins, 
which are gap-junction proteins and help in the formation of gap junctions (unpublished 
data). Thus, direct cell-cell contact dependent mechanism is a novel strategy used by Treg 
cells to use a classical second messenger to induce suppression of neighbouring T cells 
through a ubiquitous system of intercellular communication such as gap junction. A fifth 
mechanism known is that Treg cells can also directly target DCs to modulate the maturation 
and/or function of DCs that are necessary for the activation of T cells. CD4+CD25+ Treg cells 
express CTLA-4 molecules which interacts with CD80 and/or CD86 on the surface of DCs to 
induce production of indoleamine 2,3-dioxygenase (IDO), which is an immunosuppressive 
molecule made by DCs and is a negative signal for T-cell activation (Fallarino et al., 2003; 
Mellor and Munn, 2004). Furthermore, Lymphocyte-activation gene 3 (LAG3), a CD4 
homologue selectively expressed on activated T cells bind to MHC Class II molecules 
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expressed by immature DCs inducing suppression of DC maturation and their 
immunostimulatory capacity (Huang et al., 2004; Workman and Vignali, 2005).  
In the context of retroviral infections, it was postulated that infection of DCs leading to defect 
in maturation is an escape mechanism used by FV to specifically expand Foxp3+Treg cells 
(Balkow et al., 2007). In vitro suppression of CD8 T cells by Treg cells was not mediated by 
the immunosuppressive cytokines IL-10 (Dittmer et al., 2004; Iwashiro et al., 2001a), but 
required coordinated effect of TGF-ß and the molecule CTLA-4 (Iwashiro et al., 2001a). 
Furthermore, FV induced Treg cells didn’t express granzymes, thus ruling out granzyme-
dependent Treg mediated apoptosis of effector T cells (unpublished data). There is plethora 
of mechanisms possibly used by Treg cells to render immunosuppression of effector T cells, 
however, which mechanism is precisely used is still unknown. Investigation of mechanisms 
responsible for immunosuppression of effector T cells can be simplified by using molecular 
tools such as gene array technology for screening genes expressed by virus-induced Treg 
cells. siRNA technology is also a helpful tool in knocking down the genes of interest in these 
assays to determine the molecular mechanisms underlying Treg-mediated T-cell dysfunction.  
Our studies have established a critical role for CD4+ T cells in controlling viral spread and 
onset of erythroleukemia in an indirect manner through the maintenance of CD8 and 
neutralizing antibody responses during acute FV infection. A direct anti-viral role for CD4+ T 
cells using FV-specific transgenic mouse model has been shown during the early phase of FV 
infection. Loss of anti-viral effects of CD4+ T cells occurring in the later phase was directly 
associated with the contemporaneous presence of Treg cells thereby contributing towards 
viral persistence. Depletion of Treg cells during FV infection resulted in an augmented anti-
viral T cell response and superior control of virus replication. Hence, down-regulation of 
Treg responses during infections with lymphotropic viruses such as FV might still be an 
interesting therapeutic approach. However, prolonged deletion of Treg cells has been 
reported to result in autoimmune diseases in newborn and adult mice (Lahl et al., 2007; Lund 
et al., 2008) questioning whether a therapy based on suppression of Treg cells or their 
function would be beneficial. However, the short-term depletion of Treg cells that we applied 
in the current study did not result in severe immunopathology even during an ongoing anti-
viral immune response. The findings presented here have implications for vaccination against 
viruses that escape immunesurveillance to establish persistent infections. Our results should 
encourage researchers to develop new reagents to manipulate Treg and Th cells in vivo that 
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may then be used for the therapy of acute or chronic infections with lymphotropic viruses. 
Additionally, our results also highlight the importance of genetic background in induction of 
potent CD4 T cell immunity. Therefore, apart from targeting effectors of cellular and 
humoral immunity, influence of genetic heterogeneity on T and B cell immune responses is 
central for an effective vaccine in order to confer total protection against infectious 
pathogens.  
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SUMMARY 
Specific immune T lymphocytes play an important role in the resistance to a variety of viral 
disease. In the past few years, the Friend retroviral (FV) model has been extensively used to 
study the mechanisms of immunity against retroviruses. These studies have provided insights 
into fundamental roles of CD8+ T cells in spontaneous recovery from acute FV infections and 
Helper T (Th) cells in the control of chronic FV infection. However, prominence of Th cell 
immunity in acute FV infection was not well-defined. The primary aim of our study was 
therefore to investigate the role of Th cells in recovery from acute FV infection. In vivo 
depletion of CD4 T cells largely affected the normal recovery process from FV-induced 
disease in high recovery mice with depleted animals progressing to fatal eryhroleukemia.  
Absence of CD4 T cells also accelerated viral replication and spread in spite of an intact CD8 
T cell compartment. This suggested that recovery from acute FV infections required 
coordinated CD8 and CD4 T-cell mediated immune responses. In many viral infections, CD4 
T cell help is required for the maintenance of CD8 effector responses and expansion of 
memory CD8 T cells. Thus, FV-infected mice depleted of CD4 T cells were investigated for 
the influence of Th cells on the levels of effector and memory CD8 T cells. Early recovery 
from FV infection mediated by CD8 T cells didn’t require any help from CD4 T cells but 
long-term maintenance of effector and memory CD8 T cells was dependent on CD4 T cells. 
CD4 T cells were also critical for aiding B cells for induction of neutralizing antibodies in 
response to FV. Genetic heterogeneity of mice influences susceptibility to FV-induced 
disease. An MHC class-II tetramer based analysis of FV-specific Th cell responses during 
acute FV infection demonstrated peak tetramer-positive CD4 T cell responses far greater in 
magnitude in high recovery mice than intermediate recovery mice. Owing to the presence of 
two H-2Ab alleles in high recovery mice, they were able to present more CD4 epitopes and 
therefore induced potent immune responses against FV unlike intermediate recovery mice 
with only one H-2Ab allele. FV-specific T-cell receptor (TCR) transgenic CD4 T cells were 
transferred into FV infected mice to perform a detailed kinetic analysis of anti-retroviral CD4 
T cell responses during acute FV infection. Adoptively transferred FV-specific Th cells were 
able to produce anti-viral IFN-γ and reduced viral loads in recipient mice. However, at 3 wpi, 
Th cells with effector phenotype lost their ability to produce IFN-γ resulting in loss of their 
anti-viral activity. The functional impairment of FV-specific CD8 T cells in persistent FV 
infections was shown to be mediated by Regulatory T (Treg) cells. Treg-mediated 
immunosuppresion is one of the strategies used by viruses to evade immunesurveillance in 
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their hosts.  In order to dissect the role of Tregs in mediating immunosuppression of FV-
specific Th cells, we used DEREG mice in which Treg cells can be experimentally depleted. 
Absence of Treg cells led to a significant increase in the frequency of IFN-γ producing FV-
specific Th cells. Enhancement in IFN-γ production increased the antiviral activity of CD4+ T 
cells. Thus, Treg cells can cause immunosuppression of Th cell immunity and contribute 
towards viral persistence. Considered together, our findings imply that therapeutic 
manipulation of Treg / Th – cell number and/or function could improve immune control of 
retroviral infections. Strategies for vaccine development also need to take into account the 
genetic diversity of MHC genes that can influence resistance or susceptibility to several 
different infectious diseases.  
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9. Appendix 
 
9.1. Abbreviations 
 
Abbreviations Full name 
7AAD 7-Amino-Actinomycin D 
AEC 3-Amino-9-Ethyl-Carbazol 
AIDS Acquired Immune Deficiency Syndrome 
Ab Antibody 
APC Antigen presenting cells 
APC Allophycocyanin 
BSA Bovine Serum Albumin 
°C Degree Celsius 
CD Cluster of differentiation 
CTL Cytotoxic T cells 
CTLA-4 Cytotoxic T-Lymphocyte Antigen 4 
DC Dendritic T cells 
DEREG Depletion of regulatory T cells 
DMEM Dulbecco’s Modified Eagles’s Medium 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid 
d.p.i Days post infection 
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DT Diphtheria toxin 
DTR Diphtheria toxin receptor 
dsRNA Double-stranded RNA 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraaceticacid 
Env Envelope protein 
FACS Fluorescence Activated Cells Scanner (Flow cytometer) 
FCS Fetal Calf Serum 
FFU Focus Forming Units 
FITC Fluorescein isothiocyanate 
Fig Figure 
F-MuLV Friend Murine Leukemia Virus 
Foxp3 Forkhead box P3 
FV Friend Virus 
g Gram 
Gag Group specific antigen 
GFP Green fluorescent protein 
GM-CSF Granulocyte-Macrophage colony-stimulating factor 
GTP Guanosine triphosphate 
h Hours 
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HBV Hepatitis B Virus 
HCV Hepatitis C Virus 
HSV Herpes simplex virus 
HAART Highly Active Antiretroviral Therapy 
H-2 Histocompatibility-2 
HIV-1 Human Immunodeficiency Virus Type 1 
HIV-2 Human Immunodeficiency Virus Type 2 
HRP Horse Radish Peroxidase 
HLA Human leukocyte antigen 
HTLV-1 Human T-Cell Leukemia Virus-1 
IAV Influenza A Virus 
IFN-γ Interferon gamma 
IFNAR Interferon-α Receptor 
Ig Immunoglobulin 
IL Interleukin 
i.p. Intraperitoneal 
i.v. Intravenous 
JAK Januskinase 
kDa Kilodalton 
l Liter 
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LCMV Lymphocytic choriomeningitis virus 
L. monocytogenes Listeria monocytogenes 
LTR Long Terminal Repeat 
M Molar 
MCMV Mouse Cytomegalovirus 
mDCs Myeloid Dendritic cells 
mg Milligram 
MHC Major histocompatibility complex 
min Minute 
ml Millilitre 
µl Microlitre 
mM Millimolar 
MAb Monoclonal antibody 
MMTV Mouse mammary tumour virus 
Mo-MuLV Moloney-Murine leukemia virus 
PyV Polyoma virus 
mRNA messenger RNA 
NFκB Nuclear Factor κB 
NK Natural Killer cells 
ODN Oligodeoxynucleotide 
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PAMPs Pathogen-Associated Molecular Patterns 
PBS Phosphate Buffered Saline 
PCR Polymerase chain reaction  
pDC Plasmacytoid Dendritic cells 
PE Phycoerythrin 
pH -log [H+] 
PKR Protein kinase R 
Pol Polymerase 
PRP Pathogen Recognition Receptors 
qPCR quantitative PCR 
RNA Ribonucleic acid 
RNase Ribonuclease 
Rpm Revolutions per minute 
RPMI-1640 Roswell Park Memorial Institute Medium 1640 
RSV Respiratory Syncytial virus 
R.T Room temperature 
SARS Severe Acute Respiratory Syndrome 
SFFU Spleen Focus Forming Units 
SFV Simian Foamy Virus 
SHFV Simian Haemorrhagic Fever Virus 
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SIV Simian Immunodeficiency Virus 
ssRNA Single stranded-RNA 
STAT Signal Transducer and Activator of Transcription 
SV5 Simian Parainfluenza Virus 
Tet  Tetramer  
TCR T-cell receptor 
TGF-β Transforming Growth Factor-beta 
Th T helper cells 
TLR Toll-Like Receptor 
TRAIL-DR5 Tumor-necrosis-factor-related apoptosis-inducing  
ligand-death receptor 5 
TNF-α Tumor necrosis factor-alpha 
tg Transgenic 
Treg Regulatory T cells 
U Units 
VV Vaccinia virus 
Vol. Volume 
VSV Vesicular Stomatitis Virus 
Y10.A (B.10A x A.BY)F1-generation 
Y10 (B10 x A.BY)F1-generation 
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